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ABSTRACT 
This project is part of a pilot study designed to establish a two dimensional gel 
electrophoresis-based protocol, which can be utilized in screening 
mutagencity/carcinogencity of uncharacterized substances. Currently, the Ames test is the 
most commonly used method, which is solely based on mutation at the genome level. In 
contrast to the genome, which is static, protein expression in a cell under a given set of 
conditions (the proteome) is dynamic. A screening method based on the proteome rather 
than the genome may prove more reliable and quantitative in predicting mutagenicity and 
carcinogenicity.   
In this project, Pseudomonas putida KT2440 was employed as the biological 
model because its genome has been completely sequenced and the strain is already 
known to be able to grow on several aromatic carbon sources. Two carbon sources were 
selected, succinic acid and phenylethylamine. The strain grew in the non-aromatic and 
aromatic carbon source respectively. Proteins were extracted at a fixed growth stage 
(mid-log phase) so that protein expression is consistent. Protein expression was then 
analyzed by two dimensional gel electrophoresis, with the hope of identifying proteins 
that are expressed in response to phenylethylamine – the proteomic signature for 
phenylethylamine. In total, six signature protein spots were found. In addition to 
identifying these signature protein spots, a major goal of this project (to establish 
standard protocols for protein expression and analysis) was accomplished.   
Based on the results obtained in this project, several directions for further 
improvement in later stages of the procedure are also discussed.  
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 To establish a protocol, a series of variables are considered, for example, 
biological model, approach, experimental conditions. This section describes the 
background information for this project, i.e., the basis of selection.  
This section is divided into four major parts. The first part “Mutagenesis and 
Carcinogenesis” defines the term of mutagenesis and carcinogenesis, explains the 
relationship between mutagenesis and carcinogenesis, also describes methods commonly 
used to determine the mutagenic and carcinogenic properties of chemicals. The biological 
models used for detection of mutagenesis and carcinogenesis are detailed along with their 
advantages and drawbacks.  
The second part “the Ames Test” focuses on the principle behind the test as well 
its reliability in screening.  
The third part covers background information on Pseudomonas putida KT2440, 
the biological model of this project. The description includes genus Pseudomonas, 
species putida and strain KT2440. Based on the complete genome sequence of P.putida 
KT2440, putative gene products and metabolic pathways are proposed. In addition, a 
series of compounds are known to be carbon source for the strain growth, indicating the 
range of candidate substrates for this strain.  
The last part introduces the technique of two-dimensional polyacrylamide gel 
electrophoresis (2-DE), which holds a central position in proteomics research. A variety 
of methods and tools for proteomics will be compared. The advantages and limitations of 
2-DE will also be evaluated extensively.  
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1. Mutagenesis and Carcinogenesis 
1.1 What is mutation and what effects do mutations have? 
A mutation is a change in the inherent materials, usually DNA sequence of a gene, 
which may have toxic effects. A mutagen is the agent that causes the mutation. The 
replication of DNA passes a mutation from the mutated parental cells to its progeny. A 
mutation can result in the gain or loss of certain functions, or even worse, cell death. If 
the mutation occurs in the germ cells (egg or sperm cells), the gene pool could be 
affected in a way catastrophic to the species. On the other hand, when the mutation 
occurs in somatic cells, it may cause a series of hazardous physiologic changes to the 
individual. Among somatic cell mutations, carcinogens (the agent leading to the 
occurrence of cancers) are of greatest concern. It should be noted that not all mutations 
are detrimental. Under certain circumstances, mutations may even be beneficial to the 
individuals and possibly lead to evolution in the species [1]. 
Currently, there are two major known factors in the environment which can lead 
to mutations: ultraviolet radiation and chemicals. As a matter of fact, there has been a 
constant and dramatic increase in the number of chemicals synthesized and encountered 
in the environment. While chemicals are being synthesized at the rate of about 6,000 per 
week, the number of chemicals commonly used is estimated to about 65,000 out of 
greater than 4,000,000 that are known [2]. In contrast, no estimate has been done on the 
number of naturally occurring compounds found in foods, drinks, seeds, nuts, etc. [2]. The 
natural products that have been identified as the most potent carcinogens include 
aflatoxin, safrole, estragole, sterigmatocystin and cycasin [3]. Industrial chemicals 
classified as carcinogenic for humans by International Agency for Research on Cancer 
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(IARC) include 4-aminobiphenyl, benzidine, and 2-naphthylamine [2]. Later on, 
researchers realized that some of the best studied and most effective mutagens are not 
malignant to humans by themselves whereas one or more of their metabolites are 
mutagenic to cellular components. Examples of these mutagens are nitrosamines and 
other N-nitroso compounds, bisulfite, and hydroxylamines [2].  
IARC has set up a series of criteria for classifying chemicals as carcinogens. To 
date IARC has classified some 60 substances and processes as probably or definitely 
carcinogenic in humans. IARC classification is based largely on epidemiology. 
Epidemiological studies use statistical data rather than individual cases, i.e., IARC claims 
one chemical as carcinogenic mainly according to the comparative result between large 
groups of populations potentially exposed to the chemical and appropriate control groups. 
Aflatoxin is a typical case [2]. 
In fact, identification of mutagens and carcinogens in laboratories by 
experimental techniques with well-designed methods is believed to be as effective as 
statistical data however more efficient [2].  
 
1.2 Relationship between mutagenesis and carcinogenesis 
The correlation between mutagenicity and carcinogenicity has been a major 
concern in genetic toxicology [4].  There is no doubt that certain changes in DNA induce 
cancer, however, the actual relationship between mutagenic and carcinogenic properties 
of chemicals is much more complex than previously conceived. One primary reason for 
this complexity is that many assays only target the detection of cancer initiation rather 
than extending to the whole process of tumor formation, which is a multiple-step 
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progression in nature. This implies that both genetic and non-genetic events are involved. 
A wealth of data supports the hypothesis that a mutational cascade is generally required 
for the progression of carcinogenesis. It is safe to say that not all mutagenesis detected in 
short-term assays will lead to cancer. 
Regardless of the complexity between mutagenesis and carcinogenesis, 
carcinogens can be simply classified as genotoxic and putative nongenotoxic. Genotoxic 
carcinogens are those positive in the Ames test, which cause mutation in heritable 
materials. In contrast, putative nongenotoxic carcinogens are those negative in the Ames 
test, in which no mutational effects are observed. It is assumed that these nongenotoxic 
carcinogens are likely to interact with mRNA, tRNA, or proteins instead of heritable 
materials [12]. Examples of nongenotoxic carcinogens include 1’-hydroxyestragole, 1’-
hydroxysafrole, methylhadrazine, and 1,1-dimethylhadrazine [13]. The Ames test is widely 
used as a first screening method to assess the genotoxic properties of a chemical and has 
provided extensive information on the mutational effect(s) on the tested subjects.  
 
1.3 Experimental methods to test mutagenesis 
With the development of techniques in cell biology, the types and sophistication 
of available mutagenicity tests are increasing. Four types of tests are commonly applied.  
The first type, classified as tests for gene mutations, detects mutations by 
analyzing DNA or its fragments. The Ames test, in vitro Chinese Hamster Ovary cell 
(CHO cell) gene mutation tests and mouse lymphoma cells assay are examples [5]. 
However, there also exists an in vivo variant to many mammalian in vitro tests. The in 
vivo variant mainly refers to the repair in mammalian organs and cells, such as eukaryotic 
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enzymes to remove nucleic acid derivatives (N7-methyl guanine, N1- and N3-methyl 
adenine, and N3- methyl cytosine, etc. [6]). Prokaryotic in vivo variants have also been 
identified. The most well-known and well-characterized repair enzymes are isolated from 
E.coli, such as enzymes repairing UV dimers and apurinic and/or apyrimidinic sites.  
Another type of test detects the mutagenicity implied by chromosomal changes in 
size, shape, or number. Three tests are included in this type [5]. The sister chromatid 
exchange test is used to test mammalian cell chromosomal breakage. Human lymphocyte 
cells, rodent and human fibroblasts are commonly included in the tests. The genetics of 
the fruit fly (Drosophila melanogaster) have been well characterized and found to be 
similar to mammals in many crucial reactions such that the fruit fly sex-linked mutations 
test is applied to detect a variety of end points. Test for aneuploidy (either more or fewer 
chromosomes than the normal chromosomal number) focuses on chromosome counts. 
The third type of test detects mutagenesis by measuring the rates or the amount of 
DNA repair. For instance, the Big Blue mouse cell line (with multiple copies of Big Blue 
λ shuttle vector in tandem, which includes the lacI transgene as a mutational target) has 
been adapted to measure rates of DNA repair and was successfully applied in a study on 
the function of p53, which plays a crucial role in prevention of cancer [9]. P53 is the most 
commonly mutated gene in human tumors [10]. 
The fourth type of tests determines mutagenesis by observing the appearance 
changes in a whole organism [11]. The availability of mutant strains enables the 
measurement in insect systems. For example, observation of eye color change in fruit fly 
is a popular method [5].  
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1.4 Proper model systems for carcinogenesis 
Humans would be the best biological model to determine the carcinogenicity of 
suspected chemicals. The obvious impossibility of using humans as in vivo test subjects 
led to the development of substitutes-animal test systems. However, the numbers and 
types of animals that can be used in research are limited by cost, availability and social 
pressure. To screen a candidate chemical, the study should include a sufficient sample 
population which is exposed to the test chemical in an adequate range of exposure levels. 
Proper controls (age, sex, diet) should be considered as well. Thus, high doses of tested 
chemical, which may be four to six orders of magnitude greater than the potential human 
exposure levels, are used to detect the induction of tumors in animals in a relatively short 
period. Such tests have identified a considerable number of chemicals as possible 
carcinogens. It is doubtful whether these positive results can be reasonably extrapolated 
to humans, who are probably exposed to very low amounts of the “carcinogen” through 
inhalation or digestion for a short period. For example, cyclamates and saccharin were 
fed to 80 rats at very high doses in an experiment. Bladder tumors were detected 78 
weeks later. Two government commissions examined all the data in this experiment and 
related studies. In the end the carcinogenicity of cyclamate was not established. The 
evidence for labeling saccharin as a carcinogen is not conclusive either [2]. 
Other difficulties in identifying carcinogenic chemicals on the basis of animal 
assays are linked to variation in sex, age groups, and the method used to introduce the 
chemical. The most dramatic differences exist between species. Benzene and 2-
naphthylamine are known human carcinogens. In the mouse bioassay, both of them gave 
positive results, whereas in the rat bioassay only benzene was positive. In an age 
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comparison experiment, a single dose of 20 mg/kg ethylnitrosourea administered to 10-
day-old Berlin-Druckrey IX (BD IX) rats led to brain tumors specifically with higher 
than 95 percent of occurrence. In contrast, no malignant effect was observed in adult rats. 
Tumors formed at many sites in these adult rats after a long period of repeated 
administration [2]. Therefore, how to correctly interpret data obtained from animal models 
remains a big issue to be solved.  
All the limitations mentioned above led to the appearance of another type of test, 
namely short-term bacterial or mammalian cell assays. The basic premise of these short-
term assays is not to test for transformation or other morphological changes related to 
malignancy of the tested chemicals, but to use mutagenesis as a criterion [2]. Among those 
so-called short-term bacterial or mammalian cell assays, the Ames test is the most widely 
used screening method.  
 
2. The Ames test 
2.1 Background information: reverse mutation 
Historically, mutations were observed when they led to phenotypic change(s) in 
the model system such as phage, the fruit fly Drosophila, and positive result obtained 
through such type of testing is defined as forward mutation. Generally, a forward 
mutation changes a wild-type allele, an alternative form of a gene, into a different one 
that has affects which can be observed and/or measured. For example, a mutation in one 
of the genes encoding color-producing enzymes in Drosophila eyes may change the wild 
type red eye to an albino-eyed mutant.  
Reverse mutation methods can be designed with an organism that has already 
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experienced a forward mutation. Reverse mutation is a restoration of a specific gene 
function changed or lost through a previous forward mutational event. The application of 
reverse mutation has been found useful because it makes very large numbers of bacteria 
suitable for mutagenesis. However, this strategy can only be successfully applied to 
existing forward mutations which have occurred at a non-lethal locus under specified 
conditions such that the model system is able to regain viability under the specific reverse 
conditions, can then be easily detected, isolated, or counted [2]. This concept of reverse 
mutation is the core of the Ames test.  
 
2.2 The Ames test 
The Ames test is named after a microbiologist, Dr. Bruce N. Ames, who 
developed the test in 1974. This simple bacterial test is used to screen mutagenicity of a 
chemical. The growth of Salmonella typhimurium depends on the presence of histidine 
either produced by the cells themselves or already contained in the medium. A mutant 
strain of Salmonella typhimurium carries a mutated gene making it unable to synthesize 
the amino acid histidine from the ingredients in the culture medium. This strain is then 
called a histidine auxotroph. This mutant strain is incapable of growing unless the 
required histidine is supplied in the medium. As a result, few colonies can be observed in 
the Petri plate. Under standard conditions spontaneous revertants occur at a fixed rate. 
Those colonies indicated in Figure 1 (A) is the spontaneous revertants.  
A reverse mutation induced by a certain chemical can regenerate the function of 
the gene so that the mutant strain will grow in the medium lacking histidine. Colonies 
form in the Petri plate as shown in Figure 1(B). When a chemical added to the growth 
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medium leads to a mutation that reverses the histidine auxotrophy (i.e., the strain can now 
grow in the absence of histidine) at a statistically higher rate than spontaneous reversion, 
that chemical is identified as a mutagen by the Ames test.  
 
Figure 1. The Ames test [14]
(A) A Petri plate containing about 109 Salmonella bacteria that are histidine auxotroph. The small 
number of visible colonies (around 27) in the plate are spontaneous revertants. 
(B) A Petri plate containing a filter-paper disc with a mutagen, which produces a large number of 
revertants that can synthesize histidine. After 2 days, the revertants appear as rings of colonies 
around the disc. 
 
As noted before, the Ames test is the most commonly used method with high 
efficiency to determine the mutagenicity of compounds. However, there are several 
drawbacks to the Ames test, which reduce its reliability in screening carcinogens.  
Human metabolism also plays a role in carcinogenesis. Carcinogens can be 
divided into two classes. One class of carcinogens exerts its toxic effect directly on the 
human cells without involvement of metabolism, whereas the other class of carcinogens 
requires activation through metabolic processes in an organism. For example, 2-
aminoflorene and 1,8-dihydroxyanthrachinone show mutagenicity after metabolic 
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activation while sodium azide and methyl methanesulfonate directly induce mutation 
without involvement of activation [66]. A further complication in the Ames test is that 
metabolism in prokaryotes differs from that in eukaryotes. The microorganism system 
used in the Ames test may fail to predict mutagenesis of a compound (false negative), or 
may over-predict mutagenicity of a compound which could be exerted on whole animals 
or humans (false positive). Those compounds identified as mutagens via the Ames test do 
not necessarily have carcinogenic activities in mammalian cells and vice versa.  
Another major reason for false negative or false positive of the Ames test is that 
many carcinogens have an affinity for a specific nucleotide sequence regardless of the 
involvement of metabolic activation. It is already known that the number of sequences 
shared between mammals and bacteria is very small [15]. In fact many compounds which 
cause mutations in bacteria have no mutagenic effect on mammals and vice versa. For 
example, known human carcinogens, arsenic, asbestos and diethylstilbestrol give 
negative results in the Ames test. However, both asbestos and diethylstilbestrol are 
positive in rat and mouse assays [5].  
To make the Ames test compatible for mammalian systems, the test has been 
typically modified by adding an extract of rat liver because the enzymes in the rat liver 
extract, such as cytochrome P450 which have the same functions in human, may 
metabolize the xenobiotics (chemicals foreign to the biologic system) to be tested. 
Therefore, the modified Ames test is able to give the answer to the question whether 
metabolic activation of a potential carcinogen is required as compared to the negative 
control. When the mutation frequency is substantially increased, or mutation occurs only 
in the presence of rat liver extract, it is apparent that the metabolic activation of the 
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potential carcinogen is responsible for the mutation. The modified Ames test involving 
rat liver extract makes a more reliable measure of the mutagenicity of a substance for 
mammals. A wide variety of carcinogens dependent on metabolic activation can be 
detected as mutagens. These include polycyclic aromatic hydrocarbons (PAHs) (e.g., 
benzo(a)pyrene, benz(a)anthracene, 7-methlbenz(a)anthracene, 7,12-
dimethylbenz(a)anthracene, and 3-methylcholanthrene) and N-substituted aromatic 
compounds (e.g., 4-aminobiphenyl, benzidine, 2-naphthylamine, 2-acetylaminofluorene,  
N-methyl-4-aminoazobenzene) [22]. 
Many identified carcinogens have been tested and the results obtained in many 
 laboratories throughout the world are being compiled. A majority of the data was 
examined in more than a dozen evaluation studies designed to evaluate the Ames test’s 
ability to predict carcinogenicity [5]. These evaluations indicate that 50 to 93 percent of  
human carcinogens are mutagens, most likely about 80 percent. Ames and his coworkers 
also reported that about 85 percent of the tested carcinogens (135 out of 158) were 
detected as mutagens [17]. These mutagenic carcinogens include direct alkylating agents, 
nitrosamines, polycyclic hydrocarbons, fungal toxins, aromatic amines, nitrofuran 
carcinogens, a variety of antineoplastic agents, and antibiotic carcinogens (adriamycin, 
daunomycin, and mitomycin C). Furthermore, a series of known human carcinogens also 
showed positive results. These include 2-naphthylamine, benzidine, cigarette smoke 
condensates, bis-chloromethylether, aflatoxin B1, vinyl chloride, 4-aminobiphenyl (see 
Table 2).  
Hundreds of common chemicals with unverified carcinogenicity have also been 
tested, and in general very few chemicals are positive in the Ames test. It can be 
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speculated that the chemicals positive in the Ames test should be considered potentially 
hazardous to human health, and need to be thoroughly tested in animal systems. 
Alternatively, appropriate epidemiologic studies should be done where extensive 
exposure to them occurred [16]. The combination of laboratory and epidemiologic data 
will supply reasonable and reliable evidence for conclusions regarding carcinogenicity.  
As a potential replacement for in vivo carcinogenicity testing, the Ames test has 
been comprehensively evaluated in different aspects: the source of activating enzymes 
from species other than rodents, various tester strains with specific genetic characteristics, 
as well as the reliability of the test alone and in a battery of tests.   
To evaluate the involvement of metabolic activation, a proper metabolic 
activation system is included as compared to the negative control (without addition of 
activation system). The S9 mix, a cofactor-supplemented post-mitochondrial fraction, is 
generally suggested [17]. This mix is prepared from the rodent livers, usually rats, treated 
with enzyme inducing agents. The addition and concentration of a metabolic activation 
system depends on the characteristics of the chemical to be tested. To test azo and diazo 
dyes, a reductive metabolic activation system becomes a better choice than S9 mix [17].  
The U.S. Food and Drug Administration suggests at least five bacterial strains 
should be included routinely as positive mutagenesis controls using diagnostic mutagens 
to confirm the reversion properties, specificity of each strain and the efficacy of S9 
mix[17]. In addition to S. typhimurium the standard strains also include E.coli and Bacillus 
subtilis [5], because of GC base pairs at the major reversion site four of S. typhimuriums 
strains used in the Ames test (TA1535, TA1537, TA97a or TA97) may not detect certain 
agents, for example, oxidizing mutagens, crosslinking agents as well as hydrazines, 
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whereas such substances may be detectable for E.coli strains (E.coli WP2 uvrA, E.coli 
WP2 uvrA (pKM101)) or S. typhimurium TA98, TA100 and TA102, all of which have 
AT base pairs at the primary reversion site. Ames and his coworkers tested several 
mutagens using different stains of S. typhimurium [17, 27]. The characteristic reversion 
pattern of the standard strains to some diagnostic mutagens is listed in Table 1. Both 2-
aminofluorene and aflatox B1 are the mutagens that require metabolic activation, 
therefore, the involvement of S9 is necessary. In contrast, methyl methanesulfonate is 
mutagenic independent of metabolic activation. Neither S. typhimuriums TA1535 nor S. 
typhimuriums TA1537 is effective in detection of mutagenicity of all the three diagnostic 
mutagtens; S. typhimuriums TA1538 detects only one diagnostic mutagen. Comparatively, 
S. typhimuriums TA100 (TA1535/pKM101 [69]) successfully detects all of the three 
mutagens and S. typhimuriums TA98 (TA1538/pKM101 [69]) is effective in detection of 
both 2-aminofluorene and aflatox B1 with strong signals.  
Table 1 Diagnostic Mutagens: For Confirming Reversion Properties of Tester Strains 
[16]






S. typhimuriums TA1535 - - - 
S. typhimuriums TA1537 - - - 
S. typhimuriums TA1538 +++ - - 
S. typhimuriums TA98 +++ ++ - 
S. typhimuriums TA100 +++ +++ ++ 
Note: S. typhimuriums TA1535 is used to detect mutagens causing base-pair substitutions; S. 
typhimuriums TA1537 and TA1538 are used to detect various kinds of frameshift mutagens; S. 
typhimuriums TA98 and TA100 are S. typhimuriums TA1538, TA1535 containing plasmid 
pKM101 respectively (i.e., TA98-TA1538/pKM101, TA100-TA1535/pKM101) to detect 
oxidizing mutagens, crosslinking agents.  
*: S9 activation required; : S9 activation not required. 
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Symbols represent the number of revertant/plate (spontaneous substracted): -, <20; +, 20-100; ++, 
100-200; +++, 200-500.  
The evaluations indicate that the Ames test alone is less predictive than animal 
tests. See Table 2, which shows the efficiency of rat bioassays, mouse bioassays and the 
Ames test in detecting mutagenicity for some known human carcinogens. 
Table 2 The Response of Known Human Carcinogens in Rodent 
Carcinogenicity and Bacterial Mutagenicity Assays [5]
Chemical Rat Bioassay Mouse Bioassay Ames Test 
4-Aminobiphenyl + + + 
Arsenic - - - 
Asbestos + + - 
Benzene - + No data 
Benzidine + + + 
bis-chloromethylether + + + 
Chromium; some 
chromium compounds 
+ - + 
Cyclophosphamide + + + 
Diethylstilbestrol + + - 
Melphalan + + + 
Mustard gas No data + + 
2-Naphthylamine - + + 
Soot, tars - + + 
Vinyl chloride + + + 
Positive Tests Ratio 9/13 12/14 10/13 
Note:  Symbol “+” represents positive results (carcinogenic to rodent or mutagenic to bacteria). 
          Symbol “-“ represents negative results (not carcinogenic or not mutagenic). 
 
The predictive reliability of the Ames test can be improved in a test battery 
through combination with short-term assays. A comparison study showed that the 
accuracy of the Ames test in six batteries of short-term tests is increased to 82 to 90 
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percent from the average 66 percent in 18 Ames tests [5]. Herein the accuracy is defined 
as the ratio of number of chemicals correctly identified to the number of chemicals tested. 
Most authorities recommend an appropriate battery consist of information from at least  
three types of tests: tests targeting gene mutation (the Ames test, mouse lymphoma test); 
tests focusing on chromosomal mutation (in vitro Chinese hamster ovary cell 
cytogenetics); and tests aiming at DNA damage (sister chromatid exchange, unscheduled 
DNA repair) [5]. The mouse lymphoma mutagenicity assay is used to determine whether a 
chemical is capable of inducing a change in cultured mouse lymphoma L5178 cells, 
which is measured as the viability in presence of trifluorothymidine. A pre-existing 
forward mutation at the thymidine kinase locus leads to the susceptibility of L5178 cells 
to trifluorothymidine [18]. In vitro assays conducted in Chinese hamster ovary cells aim to 
identify chemicals capable of inducing chromosomal aberrations (CA) or sister chromatid 
exchanges (SCE) in mammalian cells. The CA assay detects structural damage but not a 
change in the number of chromosomes. The sister chromatid exchanges test measures 
DNA damage. Increased DNA damage is associated with mutation induction and 
cancer[19].  
The Ames test has proved to be a powerful tool which has been widely applied in 
screening mutagens, including the genotoxic carcinogens. However, it is unable to detect 
those nongenotoxic carcinogens which exert effects on substances other than genetic 
materials. The limitation of the Ames test necessitates alternative screening method via a 
different concept than the Ames test, such as direct observation or measurement of 




 3. The biological system for this project: Pseudomonas putida KT2440 
      
Figure 2 Images of Pseudomonas putida by scanning electron microscopy [20]
3.1 Genus: Pseudomonas 
The genus Pseudomonas is presently assigned to the bacterial family of 
Pseudomonadaceae whose informal name is pseudomonads. Among over 140 species of 
genus Pseudomonas most of them are saprophytic, i.e., they grow upon decaying animal 
or vegetable matter. More than 25 species are related to humans [21]. Pseudomonas 
species are Gram-negative, straight or slightly curved rods with polar flagella for motility. 
Bacteria of the genus Pseudomonas are classified as the gamma subclass of the 
proteobacteria and share certain physiological properties such as chemoorganotrophic 
nutrition such that they can grow on a variety of organic substances. Other shared 
properties include aerobic metabolism, deficiency in photosynthesis, lack of nitrogen 
fixation, and absence of fermentation. 
Pseudomonads are found in most temperate, aerobic and semi-aerobic soil and 
water habitat. Because of simple nutritional requirements, the bacteria grow rapidly on 
standard laboratory media and also tend to overgrow other microorganisms that might be 
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present. They are nutritionally omnivorous as well. Some species are able to live on more 
than 100 different sources of carbon and energy. Moreover, they can degrade those 
compounds which can not be decomposed by other organisms. These refractory 
compounds include aliphatic and aromatic hydrocarbons, fatty acids, insecticides and 
other environmental pollutants. But they are ineffective in decomposing certain industrial 
polymers (e.g., Teflon and Styrofoam) and one-carbon organic compounds (methane, 
methanol, formaldehyde, etc.) [23].  
The genus Pseudomonas is a large taxonomic grouping of species with extreme 
versatility in metabolism, physiology and genetics. They engage in a diverse range of 
important activities, such as element cycling; degradation and recycling of both biogenic 
and xenobiotic organic compounds; food spoilage; growth promotion of plants; 
protection of plants from pathogens, parasitism by other bacteria; etc.  
P.aeruginosa, P.maltophilia, P.fluorescens, P.putida, P.cepacia, P.stutzeri and 
P.putrefaciens are known to cause disease in human by opportunistic (causing disease 
only when the immune system of the host has been weakened, or other damage to the 
host provides special opportunity for invasion) infections, These Pseudomonas species 
are pathogenic (giving origin to disease or to morbid symptoms) only to those who are 
already damaged or whose immune system are compromised or suppressed. P.aeruginosa 
and P.maltophilia account for approximately 80 percent of opportunistic infections 
caused by Pseudomonads. P.aeruginosa infection poses a high risk for the inpatients with 
cancer, cystic fibrosis, and burns; the fatality can be as high as 50 percent [21]. 
Opportunistic infections by Pseudomonas can cause endocarditis (exudative and 
proliferative inflammatory alterations of the endocardium, as a primary disorder or as a 
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complication of or in association with another disease) and pneumonia as well as 
infections of the urinary tract, central nervous system, wounds, eyes, ears, skin, and 
musculoskeletal system.  
Two pseudomonads species, P.mallei and P.pseudomallei, can be malignant to 
healthy individuals. P.mallei is the agent of glanders, a contagious disease primarily of 
equines which is communicable to humans. Today, P.mallei infections of equines are 
under control and rarely encountered in the western world. Melioidosis is an endemic 
glanders-like disease of animals and human pulmonary infection caused by 
P.pseudomallei. It is rare in the western hemisphere, but is still found in Southeast 
Asia[21].  
 
3.2 Species: putida 
Pseudomonas putida is a rapidly growing bacterium, frequently isolated from 
most temperate soils and waters, particularly polluted soils. It is a nutritional opportunist 
par excellence and a paradigm of metabolically versatile microorganisms that recycle 
organic wastes in aerobic compartments of the environment, playing a key role in the 
maintenance of environmental quality [24]. Its fascinating biochemistry and physiology, 
robustness, rapid growth, ease of handling in the laboratory, amenability to genetic 
analysis and manipulation make P.putida selected as a laboratory “workhorse” for 
research on soil bacteria and bacteria-mediated soil processes [25]. Furthermore, another 
unique characteristic contributes its prominence. It grows rapidly under the copiotrophic 
conditions of selective enrichments, i.e., relatively high concentrations of selected 
substrates, non-limiting minerals, high aeration and incubation temperatures of 20-30°C. 
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Thus, it frequently outgrows other organisms in manipulated enrichment in which an 
“exotic” compound is offered as the unique source of carbon and energy. Through 
plasmid-encoded pathways P.putida strains convert such “exotic” substrates to 
metabolites then converge to central metabolic pathways, which simplifies their genetic 
and biochemical analysis [26]. They also catabolize a variety of organic compounds via 
chromosome-encoded pathways, many of which occur as natural products or as fungal 
metabolites from the partial degradation of lignin [26]. This attribute reflects its extensive 
spectrum of “housekeeping” catabolic pathways and enzymes, presumably based on its 
tendency to freely acquire plasmids from other bacteria and its relaxed-specificity gene 
expression system [24]. This feature allows the expression of a wide variety of 
recombinant genes. Additionally, because they are non-pathogenic to healthy people 
P.putida are considered environmentally innocuous thus are promising candidate to 
develop safety strains for recombinant DNA experiments, and for environmental 
applications.   
There have been some reported infections associated with P.putida. Similar to 
P.aeruginosa, infections by P.putida occurred in hospitalized patients, especially those 
who have undergone invasive procedures such as placement of intravascular devices, 
urinary catheterization and intubation [21].  
 
3.3 Strain: KT2440 
Strain KT2440 is a derivative of the best characterized toluene-degrading 
bacterium P.putida mt-2, which harbors the archetypal TOL plasmid capable of 
specifying a pathway for the oxidative catabolism of toluene and xylenes via benzoate 
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and toluates, respectively [25]. The TOL plasmid pWWO from P.putida mt-2 is a 116.5 kb 
catabolic plasmid that encodes all the proteins necessary for bacterial utilization of 
toluene, m- and p-xylene, 3-ethyltoluene and 1,2,4-trimethylbenzene, as well as their 
alcohol, aldehyde and carboxylic acid derivatives via a β-cleavage pathway. TOL- strains, 
such as strain KT2440, are still able to use benzoate as sole carbon and energy source by 
the chromosome-encoded β-ketoadipate pathway [26], but there is no report on the 
metabolism of toluene or xylenes by KT2440.  
Strain KT2440 is a spontaneous restriction-deficient, plasmid-free derivative of 
mt-2. Because the normal restriction system against DNA uptake in recombination 
process is defective, it becomes a good recipient in gene transfer experiments [25]. In 1982, 
it was certified by the Recombinant DNA Advisory Committee (RAC) of the United 
States National Institutes of Health (NIH) as the host strain of the first host-vector (HV1) 
biosafety system gene cloning in Gram-negative soil bacteria. KT2440 and its rifampicin-
resistant derivative, strain KT2442, are used world-wide as hosts for analysis, cloning 
and manipulation of genes from soil bacteria, particularly genes encoding enzymes that 
degrade hydrocarbons and aromatic xenobiotics, as well as their regulation [24].  
 
3.4 Genome and metabolic analysis of KT2440 
The genome of strain KT2440 is a single circular chromosome, 6,181,863 base 
pair (bp) in length with an average guanine and cytosine (G+C) content of 61.6% 
(GenBank accession number AE015451). A total of 5420 open reading frames (ORFs) 
with an average length of 998 bp have been identified. [28] ORF is a long sequence of 
DNA without stop codon therefore may encode part or all of a protein. Preliminary name 
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and role assignments of these ORFs were stipulated. 3571 ORFs (65.9%) make for 
putative role assignments and another 600 ORFs (11.1%) are unique to P. putida. A total 
of 1037 ORFs (19.1%) encode conserved hypothetical proteins [28]. Figure 3 presents the 
genome of P.putida KT2440 along with putative role assignments. This supplies the 
theoretical basis to this project because the sequenced genome and generated role 
assignments indicate the feasibility and reasonability.   
Figure 4 represents a summary of the putative metabolic pathways which are 
available to transform a variety of aromatic compounds based on in silico whole-genome 
analysis of KT2440 [26]. All the pathways converge into the tricarboxylic acid cycle (TCA 
cycle, citric acid cycle, also called the Kreb cycle, see Appendix C). For example, initial 
steps in metabolism of phenylethylamine or phenylalkanoate would be mediated by 
different enzymes in all routes ultimately converging via phenylacetyl-CoA pathway to 
the TCA cycle. In Figure 4, the area enclosed by the dashed line, starting from 
phenylethylamine and ending at TCA cycle, is the theoretical basis of this project. 
Screening of a wide range of the aromatic substrates indicated that the strain is able to 
degrade some aromatics, such as benzoate, coniferyl alcohol, benzylamine, phenylalanine, 
phenylethylamine, etc.; while it cannot decompose others like tyramine, phenol, and 
atropine [26]. Table 3 summarizes the screening results of tested aromatics as sole carbon 
and energy source correlated with putative metabolic pathways based on genomic 
analysis. Phenylethylamine can be included as the sole carbon and energy source for 





Figure 3 Circular representation of the P. putida KT2440 genome [27]
Outer circle [27], predicted coding regions on the plus strand color coded by role categories: 
salmon, amino acid biosynthesis; light blue, biosynthesis of cofactors, prosthetic groups and 
carries; light green, cell envelope; red, cellular processes; brown, central intermediary metabolism; 
yellow, DNA metabolism; green, energy metabolism; purple, fatty acid and phospho-lipid 
metabolism; pink, protein fate/synthesis; orange, purines, pyrimidines, nucleosides, nucleotides; 
blue, regulatory functions; grey, transcription; teal, transport and binding proteins; black, 
hypothetical and conserved hypothetical proteins.  
Second circle [27], predicted coding regions on the minus strand color coded by role categories.  
Third circle [27], atypical trinucleotide composition of the genome.  
Fourth circle [27], top hits to the P.aeruginosa genome.  
Fifth circle [27], transposable elements (green), phage regions (blue), pyocins (yellow).  
Sixth circle [27], tRNAs in red. 






Figure 4 Putative pathway of P.putida KT2440 [26]
Note: Bold lettering (e.g. PhaE, PhaFOGHI) represents the putative genes products participating 
in the indicated step of metabolism.  
The region encircled by the dashed line represents the theoretical basis and target of the project.  
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Table 3 Results of Tested Aromatics with Putative Metabolic Pathways 
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Note: #: The putative pathway to degrade nicotinate is not included in the reference paper,        
however, the researchers found that it can be metabolized by P.putida KT2440.  
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3.5 Gene clusters encoding the aromatic central pathways [26]  
It is assumed that P.putida KT2440 undergoes at least four different central 
pathways to mineralize (to convert substrate into mineral or inorganic form) the aromatic 
compounds indicated in Figure 4. They are catechol, protocatechuate, phenylacetate and 
homogentisate pathways completed by the products of four gene clusters, i.e., cat gene 
products, pca gene products, pha gene products and hmg gene products, respectively. The 
pha gene cluster from P.putida KT2440 is composed of four discrete DNA segments, 
which are proposed to encode six distinct functional units. They are phaABCDP and 
phaE for β-oxidation and activation of phenylacetic acid; phaFOGHI for hydroxylation 
of the aromatic ring; phaJK and phaL for phenylacetic acid transport and dearomatization 
of the ring; phaMN for regulation of other pha clusters. Table 4 lists several genes and 
encoded products speculated from genomic analysis as well as their functions. The 
structure and function of benzoate dioxygenase (benABC gene product), catechol 1,2-
dioxygenase (catA gene product) and phenylacetyl-CoA ligase (phaE gene product) have 
been thoroughly characterized, while others such as phaABCPD gene products remain to 
be verified.   
Phenylethylamine is converted to phenylacetic acid through phenylacetaldeyhde 
in different microorganisms with the involvement of aromatic amine oxidases (catalysis 
of phenylethylamine to phenylacetaldehyde) or amine dehydrogenase (conversion of 
aromatic amines to the corresponding aromatic aldehydes). However, a gene homologous 
to those encoding aromatic amine oxidases could not be identified in P.putida KT2440 
genome. Whether phenylethylamine is degraded by an amine dehydrogenase in the strain 
remains to be characterized. Phenylacetaldehyde is further oxidized to phenylacetic acid 
 25
by a phenylacetaldehyde dehydrogenase (pad gene product). Phenylacetyl-CoA ligase 
(phaE gene product) activates phenylacetic acid to phenylacetyl-CoA. A catabolon is a 
complex functional unit integrated by different pathways that catalyzes the catabolism or 
breakdown of structurally related compounds into a common catabolite. The 
phenylacetyl-CoA catabolon in P.putida KT2440 converge the pathways involved in the 
degradation of phenylethylamine, phenylacetic acid and n-phenyalkanoic acids with an 
even number of carbon atoms into phenylacetyl-CoA (see Figure 4). Phenylacetyl-CoA 
then undergoes an oxygenation reaction by phaFOGHI gene products followed by 
cleavage of the aromatic ring by phaL gene product to yield acetyl CoA, which can then 
enter the TCA cycle.  
In addition to the information derived from complete genomic analysis, 
experimental results supply a firm basis both theoretically and practically for this 
project[26]. We chose Pseudomonas putida KT2440 as the test organism, succinic acid as 
the control compound and phenylethylamine as the test aromatic compound. With 
reference to the results gained by Reardon et al. [29], we compare the protein expression 
by the same strain grown in succinic acid to that grown in phenylethylamine with the 
help of two dimensional polyacrylamide gel electrophoresis. Our goal is to identify a set 







Table 4 The genes and their products from P.putida KT2440 [26]
  Related Gene Products 
Gene  Gene Poduct(aa)a Name Function 
phaM PhaM (199) PhaM Putative regulatory protein 
phaN PhaN (307) PhaN Transcriptional repressor 
phaA PhaA (257) PhaA Predicted enoyl-CoA hydratase/isomerase I 
phaB PhaB (263) PhaB Predicted enoyl-CoA hydratase/isomerase II 
phaC PhaC (505) PhaC Predicted hydroxyacyl-CoA dehydrogenase 
phaP PhaP (146) PhaP Predicted thioesterase 
phaD PhaD (406) PhaD Predicted β-ketoacyl-CoA thiolase 
phaE PhaE (439) PhaE Phenylacetyl-CoA ligase 
phaF PhaF (329) PhaF Component of a predicted oxygenation complex 
phaO PhaO (98) PhaO Component of a predicted oxygenation complex 
phaG PhaG (252) PhaG Component of a predicted oxygenation complex 
PhaH PhaH (177) PhaH Component of a predicted oxygenation complex 
phaI PhaI (358) PhaI Component of a predicted oxygenation complex 
phaJ PhaJ (520) PhaJ Phenylacetate transport 
phaK PhaK (417) PhaK Phenylacetate porin 
phaL PhaL (688) PhaL Predicted dearomatizing protein 
catA  CatA (311) CatA Catechol 1,2-dioxygenase 
benA  BenA (452) BenA Benzoate dioxygenase large subunit 
benB  BenB (161) BenB Benzoate dioxygenase small subunit 
benC  BenC (336) BenC Benzoate dioxygenase reductase subunit 
Notes: a. aa, number of amino acids. 
The structure and function of catechol 1,2-dioxygenase (catA gene product), benzoate 
dioxygenase (benABC gene product), and phenylacetyl-CoA ligase (phaE gene product) 
have been thoroughly characterized, while others such as phaABCPD gene products 





4. Methodology: Two Dimensional Polyacrylamide Gel Electrophoresis 
4.1 Limitation of Short-term Assays in Screening for Carcinogens 
Short-term assays in general and the Ames test in particular have been 
exceedingly useful as a preliminary screen of potentially carcinogenic chemicals due to 
ease of use, relatively high turnaround, and a much lower cost than animal tests. 
Nevertheless, one big issue is associated with this methodology: the false-negatives and 
false-positives. False-negatives occur when known animal carcinogens cause few or no 
mutations in the short-term test system whereas in the case of false-positives, the tests are 
positive in the short-term assay but have not shown carcinogenicity in animal tests. These 
false-positive chemicals may be falsely classified as mutagens. It is most probable that 
direct modification of nucleic acids is the first step, but human carcinogenesis is a 
multiple-step process. The death of mammalian cells is programmed, thus much more 
complicated. Another reason closely related to the occurrence of false-negatives rather 
than false-positives is the short-term assays are designed to detect the genotoxic 
carcinogens. In other words, they are ineffective for those carcinogens bypassing 
mutagenic pathways.  
Additionally, short-term assays generally measure mutagenicity based on single 
point mutation. They are unable to supply more information on how the mutated genomes 
are expressed. Inherently, all the results gained in short-term assays are based on the 
observation of changes in morphology and the integrated expression of proteins and other 
cellular components. Because proteins are key structural and functional molecules, 
molecular characterization of proteomes is necessary for a complete understanding of 
biological systems [30].  
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In this project, our research subjects are proteins expressed by the strain P.putida 
KT2440 grown on different carbon sources. In contrast to those short-term assays, it is 
possible to observe the protein patterns at different stages of cell growth via the method 
of two dimensional polyacrylamide gel electrophoresis (2-D PAGE or 2-DE). 
Comparatively, the Ames test shows a lack of understanding of the nature of cancer and 
cell growth, while 2-DE is able to supply more detailed information on how the test 
system responds to changes in growth conditions.  
 
4.2 Proteomics 
4.2.1 What is the proteome and what is proteomics? 
Proteome = PROTEins expressed by the genOME [30]. The proteome represents 
an array of proteins that are expressed in a biological compartment (cell, tissue, or organ) 
at a particular time, under a particular set of conditions [31]. The genome, the medium 
carrying the inherent information from generation to generation, must retain high stability 
under different conditions, thus, it supplies static information about an organism. In 
contrast, proteome is dynamic and it expresses only a fraction of genome under specific 
condition. Multiple definitions have been offered for the term “proteomics”. Yates 
defined proteomics as "the scientific discipline of characterizing and analyzing the 
proteins, protein interactions, and protein modifications of an organism” [30]. Proteomics 
is further classified into two sub-categories: structural proteomics and functional 
proteomics. The goal of the former is to define the primary, secondary, and tertiary 
structure of proteins while the latter is focused on characterizing protein function with the 
aid of the information provided by structural genomics. Gygi and Aebersold defined 
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proteomics as “the ability to systematically identify every protein expressed in a cell or 
tissue as well as to determine the salient properties of each protein, such as abundance, 
state of modification, involvement in multiprotein complexes, etc.” [30]. Others define 
proteomics simply as “the study of protein expression from cells, tissue or organism, and 
the ability to study cellular processes at the molecular level” [30].  
The complete genome of P.putida KT2440 has been sequenced. Putative ORF 
and the resulting gene products as well as metabolic pathways have been speculated [26, 28]. 
Furthermore, gene microarrays offer a snapshot of the expression of many or all genes in 
a cell through the levels of messenger RNA (mRNA). Unfortunately, the levels of mRNA 
do not necessarily indicate the levels of the corresponding proteins in a cell.  Different 
stability of mRNA and different efficiencies in translation can affect the production of 
proteins. In addition, mRNA levels are unable to supply any information on those 
proteins whose expression and activities are affected by endogenous posttranslational 
modifications and other modifications caused by external factors. Posttranslational 
modifications occur very commonly in eukaryotes but less in prokaryotes such as 
P.putida KT2440 [32]. The bacterial system is very sensitive to the cellular environment. 
They can respond to an environmental change by adapting gene expression within 
seconds to minutes, since transcription and translation in prokaryotes are closely coupled.   
The scope of proteomics is also very broad. In current practice, proteomics 
includes four principle applications. They are: 1) mining, 2) protein-expression profiling, 
3) protein-network mapping, and 4) mapping of protein modifications [32]. A brief 
description is given as follows.  
1)  Mining is the identification of all or as many of the proteins as possible in a sample. 
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Rather than inferring the composition of the proteome from expression data of genes 
(for example, microarrays), the mining catalogs the proteome directly. Mining is able 
to confirm the information only inferred from gene expression data by direct analysis, 
i.e., resolving proteins to the greatest extent then using Mass Spectrometry, database 
and/or software tools for identification.  
2)  Protein-expression profiling is the identification of proteins in a particular sample as a 
function of a specific state of the organism or cell (e.g., differentiation, developmental 
state, or disease state) or as a function of exposure to external agents (e.g., drug, 
chemical or physical stimulus). Actually, this is a specialized form of mining which is 
most commonly practiced as a differential analysis to compare two states of a 
particular system.  
3)  Protein-network mapping is the determination of protein interactions in living systems. 
Proteomic approaches offer the opportunity to characterize complex networks 
through the creative pairing of affinity-capture techniques coupled with analytical 
proteomics methods. Proteomic approaches have been used to identify components of 
multiprotein complexes involved in point-to-point signal-transduction pathways in 
cells. Protein-network profiling would be able to assess the status of all the 
participants in the pathway.  
4) Mapping of protein modifications is the identification of how and where newly 
produced proteins are modified. Many common posttranslational modifications 
govern the targeting, structure, function, and turnover of proteins, especially in 
eukaryotes. Many internal and external agents activate electrophiles to modify 
proteins. This approach is superior to detection with antibodies because antibody-
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based methods are unable to identify the precise sequence site of a specific 
modification, whereas proteomic approaches can establish both the nature and 
sequence specificity of posttranslational modifications.  
 
4.2.2 Proteomics tools 
Proteomics requires specific tools to characterize the proteome and its 
components. The integration of four important tools provides sensitive, specific means to 
undertake the task. These four tools are databases, Mass Spectrometry, software and 
protein separation technology.  
Databases, including those with proteins, expressed sequence tags (EST, a unique 
stretch of DNA within a coding region of a gene that is useful for identifying full-length 
genes and serves as a landmark for mapping) and complete genome sequences, 
collectively provide a complete list of all proteins expressed in organisms. For those 
whose coding sequences are completely known (e.g., Drosophila) we search a large but 
known index of possible proteins. When searching with limited sequence information or 
even raw mass spectral data, we can possible identify a protein component from a match 
with a database entry [32]. Fortunately, large-scale genome research has produced a 
constantly increasing number of organisms whose genomes have been catalogued in 
several databases, which can be accessed over the Internet using online search engines.  
Other bioinformatics tools have been developed to query these databases [31]. These 
database tools make proteome analysis by 2-D gels more useful combined with whole 
genome analysis, which enables to link each protein spot to its cognate gene. Table 5 lists 
several databases which are important for proteomics.  
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Table 5 List of databases and Internet links [33]
Databases Link Comments 
PROSITE  http://au.expasy.org/prosite/ Protein families and domains 
SWISS-2DPAGE http://au.expasy.org/ch2d/ Two-dimensional polyacrylamide gel 
electrophoresis 






Automatically generated protein 
models 
PDB http://www.rcsb.org/pdb/ Protein data bank 
GenBank http://www.ncbi.nlm.nih.gov
/Genbank/index.html 
Genetic sequence database, a 
collection of all publicly available 
DNA sequences 
 
 Mass Spectrometry (MS) instrumentation can provide accurate molecular mass 
measurements of intact proteins as large as 100 kDa or more, peptides from proteolytic 
digests as well as sequence analysis. All three types of analyses are very useful in 
proteomics [32]. The introduction of two “soft” ionization methods, electrospray ionization 
(ESI) and matrix-assisted laser desorption/ionization (MALDI), made MS more 
compatible for the analysis of biopolymers, proteins, nucleic acids and carbohydrates.  
These two ionization methods are called “soft” because they do not degrade the molecule 
during the ionization process. Three types of instruments are commercially available: 
MALDI time-of-flight (ToF) MS, ESI-triple quadrupole (TQ) MS and ESI ion trap (IT) 
MS [34]. MALDI-ToF MS measures the mass of peptides derived from an in-gel 
proteolytic digestion, such as trypsin. The peptide mass fingerprints are subsequently 
searched against the in-silico digestion of a protein database or a translated nucleotide 
database using the same enzyme [35]. A great advantage of MALDI-ToF MS is that the 
process of soft-ionization causes little or no fragmentation of analytes, allowing the 
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molecular ions of analytes to be identified, even within mixtures. In most case MALDI-
ToF MS alone is sufficient for reliable identification of a protein with high confidence. 
Nevertheless, MALDI-ToF MS is ineffective in unambiguous identification of small 
acidic proteins because they do not yield enough tryptic peptides [35]. When ESI-TQ/IT 
MS is used for identification, peptides are fragmented into characteristic product ions, 
which include intrinsic features for peptide sequencing. The database search of 
fragmentation pattern for each peptide requires more computer power to correlate the 
many spectra. For best protein match, tabulation of results from individual peptides is 
necessary. Generally, MALDI-ToF MS is applied for initial analysis. ESI-TQ/IT MS is 
used for samples that are not identified in the initial MALDI screen [68].  
The third essential tool is software that can match MS data with specific protein 
sequences in databases. There are software tools which can take uninterpreted MS data 
and match it to sequences in protein, EST, and genome-sequence databases with the aid 
of specialized algorithms. Table 6 shows some commonly used software tools with link.   
The fourth tool is separation and/or analysis technology. Some technologies have 
dual functions of both separation and analysis, such as two-dimensional PAGE. Other 
protein separation techniques including 1D PAGE, High Performance Liquid 
Chromatography (HPLC), capillary electrophoresis (CE), and affinity chromatography 






Table 6 List of software tools with URL [33]
Tools and Software Packages Link 
Proteomics http://au.expasy.org/tools/#proteome 
DNA to Protein  http://au.expasy.org/tools/dna.html 
Similarity searches http://au.expasy.org/tools/#similarity 
Post-translational modification and 
topology prediction 
http://au.expasy.org/tools/#ptm 
Primary structure analysis  http://au.expasy.org/cgi-bin/protscale.pl 
Secondary and tertiary structure prediction  http://au.expasy.org/tools/#secondary 
Alignment  http://au.expasy.org/tools/#align 
ImageMaster / Melanie 
Software for 2-DE analysis 
http://au.expasy.org/melanie/ 
Identify proteins using pI, Mw and peptide 
mass fingerprinting data 
http://au.expasy.org/tools/peptident.html 
 
4.2.3 Basic Methodology for 2-DE 
The general strategy of 2-DE based proteomics methodology is shown in Figure 5. 
2-DE has held its central position in proteomics research for the last three decades. 2-DE 
has several applications:  
1) Separation of complex protein mixtures into their individual polypeptide 
components;  
2) Comparison of protein expression profiles of sample pairs (cell growth with 
different stimulus, etc.).   
3) Detection of global protein expression under certain condition. For example, the 
2-DE gel might reveal the global protein profile in a given cell type or tissue 
responding to added cytokine or drug, where all the detected proteins can be 
analyzed both qualitatively and quantitatively [36].  
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2-DE is an orthogonal separation technique by which proteins are separated based 
on two distinct physicochemical properties: isoelectric point (pI) and molecular weight[30]. 
Net charges carried by protein or polypeptide are pH dependent. By definition, the 
isoelectric point (pI) of a polypeptide is the pH at which the net charge on that 
polypeptide is zero. Isoelectric focusing (IEF) resolves a mixture of polypeptides 
according to their specific pI values. Further separation based on molecular weight is 
done by electrophoresis in polyacrylamide gels in the presence of sodium dodecyl sulfate 
(SDS), hence the method is also named SDS-PAGE [37]. An outstanding feature of 2-DE 
is that the resolution obtained in IEF is maintained when the IEF gel is coupled to the 
SDS-PAGE gel. The resolution of a mixture of proteins contributes to simplify MS 
analysis. However, it is known that 2-DE combined with MS detects only the proteins 
with greatest abundance. Additional advantage of multiple dimension separation is that 
enhanced resolution can be obtained when appropriate gels are applied, such that the 
detection of proteins in low abundance can be realized [30]. Despite its limitations-low 
detection limit, poor reproducibility, lack of potential for turn key operation (those that 
do not require human intervention)-this multidimensional separation technique is widely 
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Figure 5 General strategy for proteome analysis by 2-DE, Mass Spectrometry and 
database searching [31] 
Abbreviations: MALDI-ToF-MS, matrix-assisted laser desorption/ionization time-of-flight MS; 
ESI-Q-IT-MS, electrospray ionization quadrupole ion-trap MS. 
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4.2.4 2-DE 
4.2.4.1 First dimension separation-Isoelectric focusing (IEF) 
In IEF, proteins are electrophoresed in a polyacrylamide gel with fixed pH 
gradient. Each protein molecule with the same characteristic isoelectric point (pI) 













Figure 6 The principle of isoelectric focusing [39]
(A) The sample is loaded and voltage is applied. The proteins will migrate to their isoelectric pH, 
the location at which they have no net charge.  
(B) The proteins form bands that can be excised and used for further experimentation, or the 
entire IEF gel can be applied to an SDS-PAGE gel.  
 
The introduction of immobilized pH gradients (IPGs) overcomes the poor 
reproducibility of carrier ampholyte distribution by flimsy capillary gels [38]. For example, 
IPGs avoids cathodic drift thus allowing a higher loading capacity and increased 
resolution when narrow pH gradients (approximately 0.05 pH per centimeter) are used [36]. 
The pH gradients of IPGs are generated through covalent binding of the buffering 
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compounds to porous polyacrylamide gels [37]. The structure of a polyacrylamide matrix 
is shown in Figure 7. IPG strips cast on plastic backing sheets are cut into mechanically 
stable strips and easily manipulated. With a few exceptions, 2-DE is now done almost 
exclusively with IPGs in IEF resolution. Another favorable feature of IPGs is the pH 
gradients remain fixed and remain stable over long running time at very high voltages 
during the IEF process [37].  The commercially available quality-controlled IPGs offer a 
multitude of pH ranges and lengths, ensuring the flexibility and reproducibility of the first 
dimension separation [38].  
 
 monomer cross-linker
Figure 7 Formation of a polyacrylamide matrix [37]
A three-dimensional mesh is formed by co-polymerizing activated monomer and cross-linker.  
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4.2.4.2 Second dimension separation-SDS PAGE  
The IPG strip is applied to the top of an SDS- polyacrylamide gel to undergo the 
second dimension by electrophoresis orthogonal to the first one. Proteins with the same 
pI are further separated as shown in Figure 8. 
 
Figure 8 Schematic diagram showing separation of proteins by SDS-PAGE after 
separation by IEF [40]
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The anion sodium dodecyl sulfate (SDS) binds to proteins with the ratio of 1 SDS 
per 2 amino acids, i.e., a protein consisting of 100 amino acids will bind about 50 SDS 
molecules. The denatured proteins with zero net charge after IEF attain negative charges 
with a constant ratio of charge to mass for all proteins in a mixture. These proteins 
migrate at a rate reversely proportional to the molecular weight when subjected to an 
electric field. The structure of SDS is shown in Figure 9. The reproducibility of the 
second dimension separation is improved by the availability of precast SDS-PAGE gels 
as well as devices for running multiple gels. The sufficient standardization in the 
available systems ensures the intralaboratory and interlaboratory data comparisons as 
well as collaborations [38].  
  
Na+
Figure 9 Structure of sodium dodecyl sulfate (SDS) 
 
4.3 Merits and limitations 
4.3.1 Merits 
The 2-DE based approach has several characteristics that are currently unmatched 
by other proteomics methodologies. First, a number of specific protein attributes can be 
determined. Thousands of proteins can be resolved and visualized simultaneously on a 
single 2D gel. For each protein, the isoelectric point, molecular weight and the relative 
quantity can be measured. With the data obtained from a mass spectrometer, each protein 
can be characterized via a unique peptide-mass fingerprint and/or amino-acid sequence[31]. 
The protein can be identified by searching available gene-protein databases (see Table 5). 
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Second, the high resolution of 2-DE allows the separation and detection of post-
translational modification of proteins which may lead to changes in molecular weight 
and/or isoelectric point, especially in eukaryotes. Those modified variants can be 
distinguished from the primary translated products by 2D PAGE because they appear as 
distinctive horizontal or vertical clusters of spots [31]. In addition, modified proteins can 
be revealed by MS analysis when multiple spots of the same protein are identified.  
Third, individual steps of proteome analysis-2D PAGE, imaging, MS, database 
searching-can be separated in space and time. 2D gels can also serve as high-capacity 
“fraction collectors” for the purification and long term archiving of proteins [31]. On a 
single properly dried gel, thousands of proteins can be stored at room temperature with a 
size equal to one notebook page. In this manner, proteins from precious sources such as 
rare tumor-tissue specimens can be preserved for extended period of time, from months 
to even years.   
Fourth, the 2-DE based technology is well suited for research conducted in an 
academic setting in terms of equipment and personnel resources. The equipment is 
relatively inexpensive and can be supported by individual project grants. By way of 
comparison, alternative proteomics methodologies rely on cutting-edge, high cost MS 
instrumentation. For example, a Fourier transform ion cyclotron resonance Mass 
Spectrometer (FT-ICR MS) costs over one million dollars for purchase and a lot more for 
maintenance than 2-DE devices, and requires expert operators, all of which makes this 





The greatest challenge for proteomics technology is the inherently complex nature 
of cellular proteomes. As mentioned earlier, a proteome is a highly dynamic entity. Many 
factors contribute to the complexity. Protein expression in a biological system changes 
along the state of development, in response to environmental stimuli, with the 
progression of a disease, etc. In addition, different cells within a multi-cellular organism 
have different proteomes. The number of proteins in a proteome is very large. The 
dynamic range of protein expression spans seven or eight orders of magnitude. 
Consequently, proteins are present in vastly different quantities. Furthermore, proteins 
within a proteome are structurally diverse and have various physicochemical 
characteristics. All these factors make comprehensive characterization of cellular 
proteomes an enormous undertaking [31].  
There exist mainly four technical drawbacks of 2-DE-based proteomic approaches.  
1. It is impossible to analyze the entire proteome. Proteins displayed in a single 2D gel 
represent only a fraction of all the proteins present in a sample [31]. Generally, proteins 
detected in 2D gels through conventional staining methods are those in high-
abundance [32], since the low-abundant proteins are below the detection range. The 
detection limit of silver staining is approximately 1 ng of protein [31], that of 
Commasie Brilliant Blue staining is 10 ng of protein [38]. The proteins in low-
abundance include regulatory proteins, receptors, and other proteins that play key 
roles in cellular processes. Another group of proteins with special properties are 
difficult to analyze by 2-DE under standard conditions. These proteins include very 
small or very large proteins, alkaline proteins, and hydrophobic proteins. For example, 
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the hydrophobic membrane proteins poorly dissolve in standard protein extraction 
solutions, and they are in low abundance too. There is no universal protocol that 
could be applicable to all proteomic research.  
2. The detection technique is another factor for the limitation [32]. Currently, staining is 
the commonly applied detection technique in laboratories. The dynamic range of 
protein staining is relatively small. Spots intensities reflect at most a 100-fold range 
of protein concentrations so that staining of 2D gels allows the visualization of 
abundant proteins, whereas less abundant proteins frequently can not be detected. 
Coomassie Brilliant Blue is widely used to visualize 2 D gels and more suitable than 
silver stain for protein quantification, but its sensitivity is lower than that of the silver 
stain. The accuracy of the quantification of proteins in silver stained gels is 
compromised by the narrow dynamic range of the stain, and also affected by the 
different staining characteristics of proteins. In addition, the complexity of the silver-
staining procedure may make it difficult to achieve reproducible spot intensity [31].  
3. It is difficult to perform highly reproducible 2-DE analysis [32]. This problem becomes 
a bottleneck when 2D PAGE images are used to compare protein expression. 
Differences of protein migration in either dimension could be mistaken for 
differences in levels of certain proteins between the two samples. Fortunately, the 
poor reproducibility caused by migration differences now can be compensated to 
some extent by software tools like Progenesis [56] during the stage of image analysis.  
4. 2-DE is labor-intensive and has a relatively low throughout [31]. The throughput of 2-
DE is adequate for many basic research studies. However, it is not high enough for 
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projects that involve screening of a large number of clinical samples, or for any other 
research where high throughput is critical.  
 
Reardon et al. successfully compared the protein patterns expressed by 
Pseudomonas putida F1 grown in toluene, phenol and toluene/phenol mixture, 
respectively via the technique of 2-DE and identified protein signatures [29].  
 
This project is a pilot study, part of a complicated project aiming to set up a 
complete protocol for carcinogen screening as an alternative to the Ames test, which is 
valid only for genotoxic carcinogens. The value of this protocol is that it will be an 
effective method for screening not only genotoxic but also non-genotoxic carcinogens, 
because this screening protocol will focus on the analysis of signature proteins expressed 
by the strain P.putida KT2440 in response to tested substance via the core technique of 2-
DE. This pilot study is designed primarily to verify the feasibility and to explore the 
reliability of the idea. To minimize the elements at the very early stage, neither diagnostic 
carcinogen nor S9 mix is considered in this project. A comprehensive gene analysis of 
the strain supposes that succinic acid can be directly converted to succinyl-CoA then 
entering the TCA cycle whereas phenylethylamine, an aromatic compound, is degradable 
through unverified pathway by a series of putative gene products. It is hypothesized that 
the degradation of phenylethylamine requires the participation of other protein(s) than 
those involved in succinic acid decomposition. The protein specifically responsive to 
phenylethylamine is called signature protein, which would be isolated by 2-DE and 
visualized in the image, later identified by other techniques like MALDI-ToF-MS or the 
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ProteinChip® Biomarker System [36].  
To verify this hypothesis, this project compared the protein expression by the 
same stain however grown in different carbon source to reveal signature proteins. The 
strain grown in succinic acid is considered as control; that grown in phenylethylamine is 
assigned as the test sample. Proteins are to be extracted at mid-log phase, resolved by 2-
DE, then compared by Progenesis software such that signature proteins can be found.  
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MATERIALS AND INSTRUMENTATION  
For convenience, Table 7 summarizes the commercially available reagents used in 
this project. Table 8 lists the instruments needed for different experiments. 
1. Materials 
Table 7 (A) Commercially Available Reagents Sorted By CAS Number 
Reagents Company CAS# 
Bacto-agar Difco Laboratories  
Succinic acid Sigma 6106-21-4 
Phenethylamine Aldrich 64-04-0 
Glycine Sigma 56-40-6 
Agarose Sigma Aldrich  9012-36-6 
Ribonuclease A Fisher Scientific 9001-99-4 
Glycerin J.T.Baker 56-81-5 
Table 7 (B) Commercially Available Reagents Sorted By Catalog Number 
Reagents Company Catalog # 
CHAPS FisherBiotech 75621-03-03 
Bio-Lyte® 3/10 Ampholyte Bio-Rad 163-1112 
bromophenol blue Bio-Rad 161-0404 
1.5 M Tris-HCl Buffer pH 8.8 Bio-Rad 161-0798 
10x Tris/Glycine/SDS buffer Bio-Rad 161-0732 
SDS solution 20% (w/v) Bio-Rad 161-0418 
Urea Bio-Rad 161-0731 
Iodoacetamide Bio-Rad 163-2109 
dithiothreitiol Bio-Rad 161-0611 
Bio-Rad Protein Assay Standard I   Bio-Rad 500-0005 
Ribonuclease A Fisher Scientific BP2539250 
ReadyStripTM IGP strips 
11cm, pH 3-10 
Bio-Rad 163-2015 
CriterionTM Precast Gel 8-16% Tris-HCl, 




Table 8 List of Instruments and Manufacturers 
Instruments Used In Experiments Manufacturer 
Growth curve measurement  
Spectronic 20  Cat.NO. 33.31.72 
 
Bausch&Lomb 
Harvest of cells 
Sorvall® RC 5C Plus  





SonicatorTM cell disruptor model W-375 
Sonicator® Ultrasonic convertor model no. C3   
Tip HS0305072 
 
Heat Systems-Ultrasonics, Inc. 
Heat Systems-Ultrasonics, Inc. 
N/A 
Collection of soluble proteins 
Biofuge 13 model 75003636/01 
 
Heraeus Instruments 
Protein Assay measurement 
















1. Reagent preparation 
In this project, reagents were either obtained from manufacturers like Bio-Rad or 
prepared in the laboratory from stock chemicals. These reagents include rehydration 
buffer, equilibration buffer and agarose.  
1.1 Liquid Hutner’s medium  
Hutner’s medium is made up of three different solutions: A, B and C. The 
complete recipes for these solutions can be found in Appendix A. The recipe of Hutner’s 
medium was provided by Dr. Reardon of Colorado State University [41]. After solutions 
A, B and C are prepared, they are sterilized by vacuum filtration. All the solutions must 
be stored in brown bottles or containers wrapped with aluminum foil. 
To prepare one liter of growth medium, 40 ml of solution A, 20 ml of solution B 
and 5 ml of solution C are added to sterile deionized water. Growth medium with any 
variation in total volume can be prepared based on the calculation according to this 
components ratio.  
 
1.2 Hutner’s medium plates 
To prepare Hutner’s medium petri plates, one liter of total volume will be made 
containing 40 ml of solution A, 20 ml of solution B, 5 ml of solution C. The 
concentration of carbon source (succinic acid) is controlled at 5 mM. It is necessary to 
add agar (15g/L) to solidify the medium in the plates. After all of the components are 
added, the mixture is autoclaved so that bacterial contaminants can be eliminated. The 
autoclaved medium is poured into sterile petri plates when the medium temperature is not  
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lower than 55°C, otherwise, the medium starts to solidify in the container.   
The plates are labeled and stored in a refrigerator.  
 
1.3 Growth curve medium 
To keep growth conditions constant throughout the research, the growth curve 
medium contains all three solutions of Hutner’s medium and carbon source (succinic 
acid, or phenylethylamine) at fixed concentrations. For growth on succinic acid as carbon 
source, a stock solution of 0.5 M succinic acid is used.  For growth on phenyethylamine, 
pure phenylethylamine is added directly to the solution.  
Medium for growth curve measurement is usually prepared the day before the 
measurement to reduce the risk of contamination. All the containers are autoclaved 
before use. 









Solution A 40 ml 4 ml 4 ml
Solution B 20 ml 2 ml 2 ml
Solution C   5 ml 0.5 ml 0.5 ml
Carbon source  
(0.5 M succinic acid) 
10 ml 1 ml -
Carbon source 
(neat phenylethylamine) 
- - 62.8 µL
Water Adjust to 1 L Adjust to 100 ml Adjust to 100 ml
Note:  Physical property of phenethylamine: molecular weight: 121.1816 g/mol,                                                            
density: 0.962 g/ml, melting point: -60 °C 
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1.4 Rehydration/Sample buffer 
Early in this project, 0.05 M pH 8.4 Tris-HCl buffer was added to the harvested 
cells to extract soluble proteins. To make the environment more compatible to the next 
step in the isoelectric focusing protocol, rehydration, the Tris buffer was replaced with 
rehydration buffer for the extraction. The rehydration/sample buffer is commercially 
available from Bio-Rad. However, the amount needed for the project was much larger 
than expected especially when the buffer was used for extraction. In addition, all the 
necessary components were readily available in the laboratory. Refer to Table 9.1 in the 
“2-D Electrophoresis for Proteomics, A methods and Product manual” by Bio-Rad, page 
27 for the complete recipe [50]. The following table (Table 10) shows how the rehydration 
buffer used in this project was prepared. The function of each component is included in 
the table.  
Table 10 Composition of Rehydration/Sample Buffer 
Components Amount Comments 
8 M Urea 24 g dry urea Denaturing agent 
Disrupts protein-protein interactions, 
secondary and tertiary structures 
50 mM dithiothreitiol  
(DTT) 
385 mg Reductant 
Reduces disulfide bonds and prevents 
protein oxidation 
4% CHAPS 2 g Detergent 
Helps to solubilize membrane 
proteins and aid their separation from 
lipids 
0.2% Carrier ampholytes  
pH 3-10 
250 µL 
of  40% (w/v) Bio-
Lyte apmholyte stock 
Generates and buffers pH gradients, 
improves the solubility of proteins 
Water Adjust to 50 ml  
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The anionic dye bromophenol blue is normally added to control the start and 
running conditions of SDS-PAGE, however, in this project it was not included in the 
rehydration buffer as described in the Bio-Rad manual. To compare the possible negative 
effect without the dye, IPG strips after IEF were stained for evaluation. It is found that 
the bands formed by proteins with the same isoelectric point can be clearly observed. The 
images of the 2D gels also supported the conclusion. 
 
1.5 Equilibration buffer  
Equilibration buffer is supplied by Bio-Rad in its ReadyPrepTM 2-D Starter Kit[51]. 
It is convenient and cost effective to prepare this buffer in the laboratory.  
1.5.1 Equilibration base buffer 
The equilibration base buffer is commercially available from Bio-Rad meanwhile 
it is cost-effective and convenient to constitute the base buffer in laboratory. The recipe 
applied in this project is close to that supplied by Bio-Rad. Table 11 lists the modified 
compositions of equilibration base buffer based on Table 11.1 in the “2-D 
Electrophoresis for Proteomics, A methods and Product manual” by Bio-Rad [52]. A 
minor difference is that pure glycerol is used instead of 50% glycerol indicated in the 
manual. As a result, 20 ml of glycerol is added to prepare 100 ml of the equilibration base 
buffer.   
1.5.2 Equilibration buffer I 
The reductant dithiothreitiol (DTT) is added to equilibration base buffer with the 
ratio of 2%, i.e., 200 mg DTT is added to 10 ml of equilibration base buffer, immediately 
prior to use. DTT functions to reduce disulfide bonds and prevent oxidation of proteins.  
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1.5.3 Equilibration buffer II 
The alkylating agent iodoacetamide is added to the equilibration base buffer with  
a final concentration of 2.5%, i.e., 250 mg iodoacetamide is added to 10 ml of 
equilibration base buffer. Iodoactamide alkylates the sulfhydryl groups produced by 
reduction so that the regeneration of disulfide bonds can be prevented.  
Table 11 Composition of Equilibration Base Buffer [52]
Reagents Amount Final Concentration 
Urea 36 g 6 M 
20% SDS 10 ml 2% 
1.5 M Tris/HCl, pH 8.8 gel buffer 3.3 ml 0.05 M 
100% Glycerol * 20 ml 20% 
Deionized water Adjust to 100 ml  
* The complete recipe of equilibration base buffer is adjusted according to the reagents available        
   in the laboratory.  
 
1.6 Running buffer 
100 ml of 10x Tris/Glycine/SDS buffer (Bio-Rad catalog: 161-0732) is diluted 
with deionized water up to 1 liter, i.e., the final condition of a 1x solution is 25 mM Tris, 
192 mM glycine and 0.1% (w/v) SDS, pH 8.3. The running buffer can be stored in a 
clean container for reuse.  
 
1.7 Agarose 
According to the manual from Bio-Rad [52], 0.5-1.0% of molten agarose is used as 
an overlay to secure the IPG strip positioned directly on top of the precast polyacrylamide 
gel. It can be prepared in laboratory.  
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The agarose solution is prepared by mixing 0.83 ml of 1.5 M Tris-HCl buffer pH 
8.8 (Bio-Rad catalog: 161-0798), 0.721 g of glycine (Sigma Aldrich), 0.25 g of low 
melting point agarose (Sigma Aldrich 9012-36-6), 0.25 ml of 20% (w/v) SDS solution 
(Bio-Rad catalog 161-0418) and a trace amount of bromophenol blue (Bio-Rad catalog 
161-0404, 1-2 mg) with deionized water added to a final volume to 50 ml. Before 
overlaying the IPG strip to polyacrylamide gel, the agarose should be warmed to liquid. 
The prepared agarose can be refrigerated for an extended period of time.  
 
2. Streaking plates, inoculation of liquid medium  
The bacterial strain P.putida KT2440 is stored in a -80ºC freezer. The P.putida 
KT2440 stock solution is prepared by mixing an equal volume of a mid-log phase culture 
with sterile glycerol, followed by snap-freezing in liquid nitrogen. It is thawed to room 
temperature then streaked on the Hutner’s medium plates. Figure 10 shows the steps used 
in streaking plates. The labeled plates are incubated at 30 ºC. To maintain cultures, fresh 
plates are streaked each week.  
A single colony can be picked from the plate using a sterilized inoculation loop 
then used to initiate growth in the liquid medium.  
 
3. Growth curve measurement 
Because the proteome in a biological system is dynamic, and the protein 
expression at different stages is likely to be different, it is necessary to determine a 
growth curve for P.putida KT2440 before growing cells for proteomic analysis. To 
determine the growth rates of P. putida KT2440 on two carbon sources separately, a  
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                   (A) [42]                                                    (B) [42]
 
(C) [43]
Figure 10 Streaking Plates [42, 43]
(A) Heat the inoculating wire of the loop or needle until red-hot, and be sure that the entire 
wire is sterilized. 
(B) Streak the plates with sterile inoculation loop. 
(C) Streaking a plate in details, aiming to isolate individual cells from initial inocula which 
contain thousands of cells. 
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single colony from a Petri plate was transferred to 10 ml of medium for 24 hours, so that 
the cells in the medium will be saturated. 24 hours later, one ml of the mixture was 
transferred into 100 ml of Hutner’s medium with the same carbon source at the 
concentration of 5 mM. A mixture of Hutner’s medium and the carbon source was used 
as the blank solution. The %Transmittance (%T) at 600 nm was recorded every hour. The 
reading of %T was converted to absorbance.  
The hypothetical bacterial growth curve is divided into four stages: lag phase, log 
phase, stationary phase and death phase (Figure 11(A)). 
Lag phase occurs immediately after inoculation. At this time, cells are acclimating 
to their new environmental conditions (pH, temperature, nutrients, etc.). During this 
phase, the cells produce and accumulate all the substances required for further division 
occurred in the following log phase, in spite of insignificant increase in quantities with 
time.   
Log phase is also called the exponential growth phase because the number of 
bacterial cells increases with time in exponential ratio. The conditions in this phase are 
optimal for cell growth.  
Log phase is followed by stationary phase. The further this phase proceeds, the 
harsher the conditions become because nutrients are depleted, while waste and secondary 
metabolic products are build up. The growth rate decreases to the point at which the 
growth rate is equal to the death rate. Therefore, there is no net growth in the population. 
The death phase is due to the exhaustion of nutrients and augmented toxicity from 
waste products, causing the living bacteria population to decrease with time.  
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For convenience, the cell density is generally monitored via the measurement of 
the absorbance of visible light, usually at 600 nm. See Figure 11 (B). 
      
  (A)      (B) 
Figure 11 Growth Curve [43]
(A) Theoretical bacterial growth curve. 
(B) For convenience, cell density is generally monitored via the absorbance of visible 
light at 600 nm. Mid-log phase refers to the time when the absorbance is half of 
the absorbance maximum measured.  
 
4. Sample preparation of 2-DE 
Once the growth curve was determined, sample separation could proceed.  
4.1 Cell growth 
To reflect growth curve conditions and insure that the cells were mid-log phase, 
cells were grown first in 50 ml of medium at 30 ºC for 24 hours in order to obtain a 
saturated culture. Then 10 ml of this culture was transferred to 1 liter fresh medium (a 1% 
inoculum) with a sterile pipet. The 1 liter flask was incubated in the shaker with a 
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swirling speed of 100 rpm, at 30ºC. For this project, all the cells, either grown on succinic 
acid or grown on phenylethylamine, were collected in the mid-log phase. For cells grown 
in succinic acid, the growth was stopped at 6 hours; for phenylethylamine, 10 hours.  
 
4.2 Harvesting cells 
Cells were harvested through centrifugation at 8200 rpm for 30 minutes. The temperature 
was controlled at 4 ºC to keep the proteolytic activity of proteases in the sample to a 
minimum. Otherwise, it is highly possible that proteins will be degraded during this 
step[67].  
 
4.3 Extraction of soluble proteins 
Harvested cells were transferred to a 15 ml beaker which had been cleaned with 
deionized water, acetone and dried at room temperature. The Bio-Rad manual suggests 
that 1 ml of rehydration/sample buffer needs to be added per 50 mg of crude extract; the 
typical extracts weighed around 200 mg, consequently 4 ml of rehydration/sample buffer 
was needed to match this ratio. However, it was found that the resulting protein solution 
was too dilute to be applicable for further separation and analysis. Rehydration/sample 
buffer was reduced to 1.5 ml to 2.0 ml, never more than 2.5 ml.  An additional advantage 
of this modification is to limit the consumption of rehydration/sample buffer. 
Before starting sonication, the tip was cleaned with deionized water and acetone 
and dried. The suspended cells were sonicated for three minutes followed by a 10 
minutes interval; this step was repeated three times. Throughout the procedure, the beaker 
was immersed in an ice bath to minimize the activity of proteases (which become active 
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when the temperature is increased by the sonication) and to prevent protein denaturation 
as temperatures increase above 40°C. The sonication was performed using a SonicatorTM 
cell disruptor model W-375 made by Heat Systems-Ultrasonics, Inc. 
 
4.4 Recovery of soluble proteins 
To maximize recovery of the crude extract of soluble proteins from the sonication 
step, the entire mixture was transferred to two or three 1.5 mL autoclaved microfuge 
tubes for further separation. The microfuge tubes were centrifuged in a refrigerator at 
13000 rpm for 300 minutes. The supernatant was transferred to two other sterile 
microfuge tubes and the pellet was discarded.  
 
4.5 Proteins assay 
The Bradford protein assay [44] was selected in this project to determine the total 
protein concentration of each sample.  Coomassie Blue G has an absorbance maximum of 
465 nm when it is mixed with phosphoric acid and ethanol. When the dye binds to 
protein molecules the absorbance maximum shifts to 595 nm. The assay is colorimetric, 
with the increase of proteins concentration the color of the mixture of proteins and dye 
becomes more intense. The quantitation of proteins in microgram quantities is derived 
from the proportional binding of the dye to the proteins within the linear range.  For the 
protein standard bovine serum albumin (BSA), the linear range is from 5 to 25 mg/ml. In 
the case of immunoglobulin G (IgG), the linear range of the assay is extended from 1.2 to 
25 µg/ml [45]. Beer’s law can be applied for accurate quantitation of proteins with the 
appropriate selection of concentrations. Generally, the protein concentration of a test 
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sample is determined through comparison of the absorbance of the test sample to a 
standard curve, generated by a protein standard in a series of concentrations known to 
reproducibly exhibit a linear absorbance profile in the assay.  
The Bio-Rad Bradford protein assay applied in this project is a modification to the 
standard Bio-Rad protein assay. All the materials and procedures are described in “2-D 
Electrophoreis for Proteomics, A Methods and Product Manual” page 45 [65] and Bio-Rad 
“ReadyPrepTM Sequential Extraction Kit, Instruction Manual” page 12-14 [46].  
 
4.6 Ribonuclease treatment 
Ribonuclease is an enzyme which specifically degrades RNA in the sample. 
Ribonuclease treatment contributes a great deal to the improvement of the quality of 2-D 
PAGE images because it eliminates most of the horizontal streaking caused by RNA. 
Usually, approximately 2 mg is added to each milliliter of supernatant recovered after 
sonication. If too little ribonuclease is added, it will be unable to digest the RNA 
completely in the sample; on the other hand, an excess of ribonuclease will be resolved 
and visualized in the image which would be misinterpreted as the protein spot produced 
by the sample of interest. Out of concern for the minor role of this ratio in the whole 
project and time and cost of this reagent, no experiment was included to compare the 
effects of excessive ribonuclease on the gels.  
 
5. Rehydration, isoelectric focusing, equilibration and electrophoresis 
The performance of rehydration, isoelectric focusing, equilibration, and 
eletrophoresis were done according to the instructions in “ReadyPrepTM 2-D Starter Kit 
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Instruction Manual” supplied by Bio-Rad [51]. 
5.1 Rehydration 
The protein was extracted from P.putida KT2440 using sample rehydration 
buffer. Using results from the protein assay, 200 µg of proteins are applied to the pH 3-10 
IPG strips in length of 11 cm, meanwhile, the approximate volume of both the sample 
and rehydration buffer is controlled at 185 µl. Instructions for approximate protein loads 
and approximate volumes to hydrate IPG strips are found in the Bio-Rad manual Table 
10.1 and 10.2, respectively [57].  
 
5.2 Isoelectric focusing 
Conditions for isoelectric focusing (Table 12) were taken from Reardon’s work 
on proteomics of P.putida F1 [29].  
Table 12 Configuration of IEF 
 Voltage (V) Time 
(hours:minutes)
Volt-Hours Ramp 
Step 1 of 4 300 0:06 --- linear 
Step 2 of 4 300 4:30 1350 V-hr --- 
Step 3 of 4 4000 5:00 --- linear 
Step 4 of 4 4000 6:30 26,000 V-hr --- 
 
IPG strips after IEF can be either directly jointed to the step of equilibration 
followed by electrophoresis if time permits, or stored at -20°C in rehydration tray with 
tight plastic wrapping.  
 
5.3 Equilibration  
Thaw frozen focused IPG strips first if necessary. Immediate preparation of DTT 
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equilibration buffer I and iodoacetamide equilibration buffer II prior to use is required for 
the best reductive and alkylating effects of sulfhydryl groups, respectively.  
5.3.1  DTT Equilibration  
Incubate each IPG strip in length of 11 cm in 4 ml of 2% DTT equilibration buffer 
I with gentle agitation (shaker is set up at 45 rpm/min) for 10 minutes. Collect decanted 
equilibration buffer I in designated container for environmental concern.   
5.3.2  Iodoacetamide Equilibration 
Repeat the procedure in DTT equilibration with the replacement of 2.5% 
iodoacetamide equilibration buffer II.  
 
5.4 Electrophoresis 
Dip IPG strip into 1X Tris/Glycine/SDS running buffer to wash away 
equilibration buffer II. Lay the IPG strip in IPG well of SDS-PAGE gel, then overlay the 
IPG well with pre-warmed agarose solution. Push the IPG strip down into the well with 
forceps carefully to avoid trapping any bubble beneath the strip. Leave the gel stand 
vertically in a test tube rack to allow the agarose to solidify. Place the gel into the gel box 
of Criterion electrophoresis cell and fill up the reservoir with 1X Tris/Glycine/SDS 
running buffer. The electrophoresis is run at 200 V DC for around 55 minutes depending 
on the migration of bromophenol blue. The bromophenol blue contained in the overlay 
agarose solution is an indicator of the progress of electrophoresis since it migrates fastest 
compared to proteins to be analyzed. After electrophoresis, SDS-PAGE gel is washed in 
deionized water followed by Coomassie G-250 staining.  
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6. Visualization of 2-DE gels 
Gels were stained with Bio-SafeTM Coomassie G-250 (Bio-Rad catalog 161-0787) 
for 90 minutes. According to the “ReadyPrepTM 2-D Starter Kit Instruction Manual” [51], 
the gels can stand in the container with dye overnight. However, gels left standing 
overnight with dye were inferior to those washed soon after the staining, because those 
protein spots in low abundance are shielded by the dark background caused by long 
staining time.  
Gels were placed between cellophane sheets and dried with blotter paper for long 
term storage. The dried gels were stored in large freezer bags with labels.  
Gels were scanned by Visioneer® OneTouchTM 9020 USB with software 
PaperPort Deluxe 7.0 [53]. To make the images compatible to the analysis software 
Progenesis (installed at University of Rochester) the images were converted to 8 bit form 
by the help of ImageJ 1.31v [54] then resized to 2500 in width and 1464 in height, 1200 
DPI by IrfanView software [55]. All the files are saved in the TIFF format.  
 
7. Analysis of 2-DE gels 
The images were analyzed by the software Progenesis [56]. Access to the software 
was generously provided by Dr. Howard Federoff of the University of Rochester Medical 
Center.  
Normally, the analysis work started with setting up a group composed of the 
images to be analyzed. Progenesis automatically compared and matched the images. The 
software uses a proprietary alignment technology called “warping.” In warping, the 
reference image (specified by the user) is fixed and the slave image which is to be 
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compared to the reference one is shrunken, expanded, or moved. Warping compensates 
for minor inconsistencies between 2-DE gels. Under the circumstances where the images 
were not sufficiently reproducible for Progenesis to run automatic warping, manual 
warping was done. Progenesis then uses a “spot detection” algorithm to identify protein 
spots in the images. Certain spots resulted from image background or contamination can 
be excluded based on spot intensity. With the software it is also possible to add, remove, 
or renumber spots. Different colors represent different images, for example, magenta is 
one the three colors assigned to the reference image, while green is the color for the slave 
image which would be helpful to distinguish the gels when superimposed. Brightness and 
contrast can be adjusted to the best effect. After warping, the matched spots are 
superimposed and appear as the sum of green and magenta (black). Protein patterns can 




1.  Growth curve 
To compare the protein patterns expressed by P.putida KT2440 grown in different 
carbon sources, the proteins must be produced at the same growth stage, such as the mid-
log phase at which the cell density is half of the stationary phase cell density. The growth 
curves for P.putida KT2440 grown on succinic acid and phenylethylamine are shown in 
Figure 12 and 13, respectively.  
Figure 12 shows that the strain grown in 5 mM succinic acid arrived at its 
stationary phase after 8 hours, with a corresponding absorbance A600 of 0.420. Therefore, 
mid-log phase should be at an A600 of 0.210, which occurs between 5 to 6 hours. The 
absorbance of six trials at 6 hours ranged from 0.244 to 0.252 which are close to the 
value of 0.210. Since the cell density was measured once an hour, as a result, there was 
no record between hours 5 and 6. It was determined that in further studies cell growth on 
succinic acid would be stopped at 6 hour for protein extraction. In the future, to obtain 
tested mid-log phase closer to the true value, the absorbance reading can be made every 
ten minutes starting from hour 5 to 6.   
Similarly, Figure 13 indicated that it took the same strain grown in 5 mM 
phenylethylamine much longer to reach the stationary phase, approximately 16 hours. 
The corresponding absorbance is 0.796, half of which is around 0.4. The mid-log phase 
occurs between 9 and 10 hours. For this study, the proteins expressed by cells growth on 
phenylethylamine were extracted at mid-log phase, 10 hours. Similarly, a shorter 
intermittence of ten minutes of absorbance reading can be measured between hour 9 and 
10 to determine the mid-log phase more accurately.  
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Since the inocula for these cell cultures were grown with the appropriate carbon 
source, i.e., the inocula of succinic acid was already incubated in succinic acid and the 
inocula of phenylethylamine in phenylethylamine for 24 hours, the difference in growth 
rates are intrinsic to this strain. Therefore, it will be necessary to determine the growth 
versus time course each time the growth conditions are changed, for example, when a 
known carcinogen is added to the medium.  
Absorbance vs. Growth Time



















Figure 12 Growth Curve of P.putida KT2440 in Succinic Acid 
A single colony of P.putida KT2440 grown on Hutner’s medium plate with 5 mM succinic 
acid was inoculated to 10 ml of Hutner’s medium solution with the same concentration of 
succinic acid, then incubated in a orbital shaker with the shaking rate of 45 rpm at 30°C for 
24 hours to make a saturated cell culture. Pipet 1 ml of the saturated cell culture to 100 ml of 
Hutner’s medium with 5 mM succinic acid in a flask having a projecting side arm of test tube 
for the convenience of absorbance measurement. Generally, 3 to 6 trials were prepared. These 
flasks were incubated in the orbital shaker at the same condition as described above as well as 
one more flask of Hutner’s medium and succinic acid however without cultured cells, which 
was used to blank the spectrometer at each measurement. The measurement of absorbance at 
600 nm was made every hour. Spectrometer 21 gives the accurate reading of %Transmittance 
(%T), which is later converted to number of absorbance.  
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Absorbance vs. Growth Time



















Figure 13 Growth Curve of P.putida KT2440 in phenylethylamine 
The growth curve of P.putida KT2440 grown in phenylethylamine was determined as described 
in figure 12 legend, with the replacement of 5 mM succinic acid by 5 mM phenylethylamine.   
 
2.  Modified Bio-Rad protein Assay 
The presence of certain agents (detergents and chaotropes) used to extract the 
protein from the cells interfere with many other types of assays. Therefore, the modified 
standard Bio-Rad protein assay was strongly indicated for the determination of protein 
concentration [46]. In this project, the Bio-Rad protein assay is further adapted with the 
following step: the protein samples were extracted with rehydration/sample buffer 
containing detergent CHAPS and carrier ampholytes (pH 3-10) instead of Tris buffer.  
Lyophilized Bio-Rad Protein Assay Standard I (bovine plasma gamma globulin, 
BgG) was reconstituted to a stock concentration of 14.3 µg/µl with deionized water. A 
series of dilutions of the protein standard were made to prepare a calibration curve, which 
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was plotted according to the absorbance at the wavelength of 595 nm versus the 
concentration of BgG. The calibration curve is characteristical of nonlinear for this 
specific protein assay [46]. This was also verified through regression analysis (see 
Appendix E). A typical calibration curve is shown in Figure 14. The data was fit to a 
polynomial trendline in Microsoft Excel. Both quadratic and cubic equations were given 
for a comparison. The value of R2 for cubic equation is 0.999 and that for quadratic 
equation is 0.9933. The cubic equation was chosen in this example because its R2 value 
was closer to 1 than that of the parallel quadratic equation. In this project the selection of 
equation generated by Excel was mainly judged by R2 value.  
The nature of this assay requires preparation of a new calibration curve when each 
sample is analyzed. Although the preparation work is tedious, the method had the 
advantage of producing highly reproducible standard curve throughout the project.  
Based on the equation obtained from the plot shown in Figure 14, the protein 
concentration in crude extract was determined by solving the equation with the online 
cubic equation calculator [47]. If the standard curve is quadratic, the corresponding online 
quadratic solver is also available [48].   
The calculated protein concentration is considered reliable only if its absorbance 
value falls within the range of the calibration curve. For example, unknowns analyzed 
based on the data in Figure 14 should have absorbance values between 0.464 and 1.821. 
However, it occurred with high frequency that the crude extract was so concentrated that 
the resultant absorbance was beyond the absorbance given by the highest standard. To 
insure that absorbance values from such a sample would fall in the range determined by 
standard BgG, a series of dilutions were required. For instance, 5 dilutions were done by 
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mixing 60 µl, 50 µl, 40 µl, 20 µl and 10 µl of crude extract with 40 µl, 50 µl, 60 µl, 80 µl 
and 90 µl of deionized water respectively to make up of a total volume of 100 µl for each 
dilution fraction. The dilutions ratios were dependent on the concentration of crude 
extract. Normally, at least three different dilution ratios were selected. One example is 
shown as follows: 
Crude extract of P.putida KT2440 grown in 5mM succinic acid on Feb. 12, 2004 
gave an absorbance of 2.008, which was out of the calibration range. 1:1 dilution, i.e. 50 
µl of crude extract to 50 µl of deionized water, was first tried; the reading was 1.900, 
which was yet not low enough to meet the criterion. Consequently another three dilutions 
with the ratio of 2:3, 1:4 and 1:9 were done, i.e., 40 µl, 20 µl and 10 µl of crude extract 
were diluted to 100 µl each, resulting in the absorbance of 1.754, 1.382, and 1.035 with 
the corresponding protein concentration of 13.113, 6.149 and 3.077 µg/µl, respectively, 
according to equation of regressed curve by Microsoft Excel. The concentration of crude 
extract can finally be determined with the related dilution ratio. The average 
concentration of the crude extract,  3 1 4 3 2  µ g / µ l,  was used in the further step  
of rehydration loading.  
Table 13 and 14 list the protein concentrations obtained in the project.  
Following the example above, the sample volume in the step of rehydration 
loading should be: 200 µg / 31.432 µg/µl = 6.36 µl, and the volume of rehydration buffer 
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Figure 14 Calibration Curve for the Bio-Rad Protein Assay, bovine gamma globulin 
Cubic regression curve is shown in solid line with the equation:  
y = 0.0005x3 – 0.0171x2 + 0.2376x + 0.4513  R2 = 0.999 
Quadratic regression curve is shown in dashed line with the equation:  
y = -0.0064x2 + 0.18x + 0.5037      R2 = 0.9933 
A series of diluted standard solution of bovine gamma globulin (BgG) were first prepared. 0, 5, 
10, 15, 20, 30, 40, 50, 60, 70, 80, 90 and 100 µl of stock solution (14.3 µg/µl) were mixed with 
different volumes of deionized water to make up a total volume of 100 µl for each dilution 
fraction. Mix 20 µl diluted standard solution and 80 µl 1M HCl solution then add 5 ml of diluted 
dye (Bio-Rad Protein Assay Dye Reagent concentrate: deionized water = 1:4 v/v). Let the 
mixtures stand at room temperature for 5 minutes followed by absorbance measurement at 595 
nm. The example indicated in Figure 14 showed the lowest absorbance of 0.464 and highest 
absorbance of 1.821. The absorbance of protein samples should fall in the range given by the 






Table 13 Determination of Protein Concentrations in Crude Extracts of  
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02-12-04 60 2.008       
  50 1.900       
  40 1.754 13.113 32.783   
  20 1.382 6.149 30.745   
  10 1.035 3.077 30.770 31.4325
03-22-04 60 1.818 14.372 23.953   
  50 1.756 13.162 26.324   
  40 1.636 10.424 26.060   
  20 1.211 4.426 22.130   
  10 0.890 2.163 21.630 24.019
04-01-04 60 1.732 12.634 21.057   
  50 1.654 10.830 21.660   
  40 1.564 8.901 22.253   
  20 1.121 3.695 18.475   
  10 0.841 1.881 18.810 20.451
04-07-04 60 1.705 12.021 20.035   
  50 1.639 10.485 20.970   
  40 1.525 8.191 20.478   
  20 1.136 3.810 19.050   
  10 0.825 1.792 17.920 19.691
04-14-04 50 1.714 12.228 24.456   
  40 1.656 10.877 27.193   
  20 1.264 4.902 24.510   
  10 0.984 2.739 27.390 25.887
Note:  Absorbance in shading were omitted in calculations because they were not in the range of 




Table 14 Determination of Protein Concentrations in Crude Extracts of  








Concentration of  
Diluted  
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02-18-04 60 1.250 4.771 7.952   
  50 1.176 4.129 8.258   
  40 1.060 3.250 8.125   
  20 0.800 1.655 8.275   
  10 0.638 0.835 8.350 8.192
03-22-04 60 1.902       
  50 1.815 14.318 28.636   
  40 1.688 11.632 29.080   
  20 1.240 4.683 23.415   
  10 0.894 2.187 21.870 25.750
04-01-04 50 1.799 14.017 28.034   
  40 1.648 10.692 26.730   
  20 1.248 4.753 23.765   
  10 0.939 2.455 24.550  25.770
04-07-04 60 1.761 13.261 22.102   
  50 1.672 11.250 22.500   
  40 1.512 7.972 19.930   
  20 1.138 3.826 19.130   
  10 0.847 1.914 19.140 20.560
Note: Absorbance in shading were omitted in calculations because they were not in the range of   








3. Rehydration of IPG strips 
The determination of protein concentration is an indispensable intermediate step 
for the following separation and further analysis. To make the protein pattern expressed 
on gels comparable, the loading amount of protein sample to IPG strips was kept constant 
at 200 µg, the total volume of sample and rehydration buffer at 185 µl [57]. Since the 
protein concentration of each sample varied, the loading volume of sample as well as the 
volume of rehydration buffer must be adjusted to meet the requirement on amount and 
volume. The example of calculation is shown in 2. Modified Bio-Rad Protein Assay. The 
volumes of each sample and rehydration buffer needed for rehydration were listed in 
Table 15 and 16 for P.putida KT2440 grown in succinic acid and phenylethylamine, 
respectively.  
Table 15 Volumes for Rehydration, P.putida KT2440 in Succinic Acid 5mM 
   Sample Preparation  
                           Date 
Volume for  
Rehydation (µl) 
03-22-04 04-01-04 04-07-04 04-14-04 
Sample  8.33 9.78 10.16 7.73
Rehydration buffer  176.67 175.22 174.84 177.27
Note: The sample prepared on 02-12-04 was not used for further analysis in this project because 
too much ribonuclease was added to eliminate contamination from RNA. The excessive amount 
of ribonuclease had the potential to disrupt the protein migration patterns in IEF and SDS-PAGE.  
 
Table 16 Volumes for Rehydration, P.putida KT2440 in Phenylethylamine 5mM 
   Sample Preparation  
                           Date 
Volume for  
Rehydation (µl) 
02-18-04 03-22-04 04-01-04 04-07-04 
Sample  24.41 7.77 7.76 9.73
Rehydration buffer  160.59 177.23 177.24 175.27
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4. Ribonuclaease treatment 
The presence of nucleic acids interferes with separation of protein because of the 
negative charge on RNA and DNA. Most DNA was disrupted in the process of extraction 
by the sonication then aggregated in the pellet generated in the following 5 hours of 
centrifugation. RNA has lower molecular weight than DNA and therefore cannot be 
removed completely by the centrifugation. The remaining RNA not only interferes with 
IEF resolution but also causes severe horizontal streaking in the SDS-PAGE gels. 
Addition of ribonuclease specially degrades RNA and minimizes the effect of RNA in gel.  
Figure 15 shows the improvement of resolution after ribonuclease treatment. 
Figure 15 (A) is the gel image of P.putida KT2440 grown in 5 M succinic acid without 
ribonuclease treatment, which has horizontal streaking and heavy background. Figure 15 
(B) is the gel image of the same strain grown in 5 M succinic acid treated with 
ribonuclease, in which the horizontal streaking was decreased substantially and the 
background became clear. Addition of 150-300 U of endonuclease to each 1 ml of sample 
mixture is suggested in the Bio-Rad manual [60]. Ribonuclease A from bovine pancreas 
used in this project has the activity of 94.7 U/mg, thus 2 mg of ribonuclease A was added 










Figure 15 Comparison of Ribonuclease Treatment   
(A) No ribonuclease treatment of protein extracted from P.putida KT2440 grown in succinic acid; 
(B) Ribonuclease treatment of protein extracted from P.putida KT2440 grown in succinic acid. 
200 µg crude extract was mixed with rehydration buffer to make up a total volume of 185 µl was 
uploaded to IPG strip then separated by IEF (0-300 V in 6 minutes with linear ramp; 300 V 
constant for 4 hours 30 minutes; 300-4000 V in 5 hours with linear ramp; 4000 V constant for 6 
hours 30 minutes), followed by SDS-PAGE (200 V constant for 50-55 minutes).  
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5. Gel images 
A brief description of how the protein patterns on the gels were converted to 
digital images then analyzed by Progenesis software is included in the sections on 
visualization and analysis at Experimental Methods section.   
The software Progenesis has a setting to select digital files as the reference gel 
and slave gel respectively when they are overlaid to match. Thereafter, the software 
keeps the reference gel(s) rigid all the time and labels the protein spots with a magenta 
color while it moves the protein spots, which are colored green on the slave gel(s), in 
order to compare the gels. This process is called warping. After warping, those matched 
spots turn dark or black. This software has two options for warping: either automatic or 
manual. Figure 16 shows how the spots on the slave gel were manipulated by manual 
warping since the automatic warping was unsuccessful (see below). The arrows indicate 
the vectors by which the spots on slave gel were moved to match the corresponding spots 
on reference gel. The matched spots were “pinned” so that they would not be moved 
away when the next warping was being done. 
In studying protein expression of P.putida KT2440 by 2-DE, three sets of 
comparisons have been done: comparison of images from cells grown on succinic acid; 
comparison of images from cells grown on phenylethylamine; and comparison between 
images from the two sets of images. The first two comparisons were designed to evaluate 
the reproducibility of this method. The puropose of the third comparison was to identify 
signature proteins that could reflect how the strain adjusts its protein expression in 





pH 3                                                                                                                   pH 10 
Low MW 
Figure 16 Overlaid and Warped Image with Vectors 
To ensure the comparability of gel images from each sample, the loading amount of 
crude extract was fixed at 200 µg regardless of the variable concentration of individual 
extraction. The magenta colored image represents the reference gel which is fixed during the 
procedure of warping. The green colored image represents the slave gel which is warped to match 
the corresponding spots on the reference gel image. The spots with dark color are matched spots. 
The cyan colored vectors (arrows in the image) indicated the manipulation of spots on slave gel to 
match the corresponding ones on reference gel. The same colored pins were used to “fix” the 
matched spots. Generally, the vectors and pins are not showed in overlaid and warped image 








5.1 Images from cells grown on succinic acid 
In this set of comparison, three gels were organized into one group. Among the 
three images, one was randomly selected as the reference gel by the software Progenesis. 
The other two gels were referred to as slave gels (see Figures 17 and 18). 
As the succinate gel set was constructed, the software did the comparison and 
match work automatically. Despite repeated efforts, the software reported that the images 
did not match. Manual warping and matching had to be done to evaluate the 
reproducibility of images. The slave gels were manually manipulated to match the 
reference gel because the gels had been shrunk or expanded to different extent. The 
manual warping work was performed according to those spots marked on the reference 
gel simply because their high intensity made observation followed by manipulation of the 
spots on the slave gel images easy. For example, the smear of protein outlined with a 
rectangle in Figure 17 and 18 is one of those marks. Since these three images were from 
the same sample, it was expected that they should be almost identical. Figure 17 and 18 
indicate that the expected reproducibility was not as high as was expected.   










 pH 3                                                                                                                 pH 10 
Low MW
Figure 17 Overlaid and Manually Warped Images from Succinic Acid (1) 
The magenta colored image represents the reference gel (from cells grown in succinic acid) which 
is fixed during the procedure of warping. The green colored image represents the first of the slave 
gels (also from cells grown succinic acid but on different dates) which is warped to match the 
corresponding spots on the reference gel image. The spots with dark color are those matched 




pH 3                                                                                                                  pH 10 
Low MW
Figure 18 Overlaid and Manually Warped Images from Succinic Acid (2)  
The same color scheme that was followed in Figure 17 is used to compare the second succinate 
slave gel to the succinate reference gel. 
 
5.2 Images from cells grown on phenylethylamine 
Figure 19 and 20 are the overlaid, manually warped images of gels run from 
protein samples obtained from P.putida KT2440 grown on phenylethylamine on different 
dates. Again the Progenesis software selected one gel at random as the reference gel and 
the other two as slave gels. Figure 19 and 20 compare each of the two slave gels (protein 
spots are green-colored) with the reference gel (protein spots are magenta-colored). The 
automatic alignment of the gels by the software Progenesis failed and the image had to be 
warped manually. As was seen with the succinic acid gels, the reproducibility was lower 
than expected. Approximately 20 protein spots were found to be present on all three gels. 
In addition, fewer prominent spots on the images from cells grown on  
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phenylethylamine were observed when compared with images from cells grown on 
succinic acid. The figures also show that the background of the reference gel was not as 
clear as that of the succinic acid gel set.  
 
High MW 
pH 3                                                                                                                  pH 10 




pH 3                                                                                                                  pH 10 
Low MW
Figure 20 Overlaid and Manually Warped Images from Phenylethylamine (2) 
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5.3 Comparison between images from cells grown on succinic acid and 
phenylethylamine 
The following four figures (Figure 21 through 24) indicate the possible signature 
proteins expressed by the test strain grown in phenylethylamine. In this group of 
comparison, gels from P.putida KT2440 grown in succinic acid were assigned as the 
reference image. The difference of the reference images between Figure 21 through 23 
and Figure 24 is that an average image of all the candidate gels generated by the 
Progenesis software was the chosen as the reference gel for Figure 24. A single image 
with good quality (predominant spots and clear background) among the candidate images 
was selected as the reference for Figure 21 through 23. The average image tested here 
was an attempt to seek improvement of comparison result. Each single image from the 
strain grown in phenylethylamine was overlaid on the reference images and manually 
warped. Unfortunately, the creation of an average image of the reference gels was not a 
promising solution, at least at the current stage of study.  
As described above, the spots on reference gel are magenta-colored, those on 
slave gel are green-colored, and the matched spots turn dark. Only those lightly green-
colored spots are candidates for inclusion in the phenylethylamine proteomic signature. 
The four overlaid images revealed six spots circled and numbered in the four figures, 
which may be signature proteins. Since not all the six spots are observed in the four 
images, the summary of spots distribution is listed in Table 17. Spot 1, 2 and 5 are 
present in all four of the images. Spot 3 and 6 are present in three of the four images, 
while spot 4 is found only in Figure 21. Spot 1, 2, 3, 5 and 6 may represent part of the 




pH 3                                                                                                                          pH 10 
Figure 21 Overlaid and Warped Images from Succinic Acid and Phenylethylamine (1) 
Note: In this group of gels, the color of magenta still represents the reference gel image. The gel 
from succinic acid was picked up as the reference gel with the color of magenta. The color of 
green represents the slave gel image, from the phenylethylamine samples. The round circles on 
the graph represent the possible signature proteins expressed by P.putida KT2440 grown in 
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Figure 24 Overlaid and Warped Images from Succinic Acid and Phenylethylamine (4) 
Note: The reference gel in this figure is the average gel from succinic acid created by the   




Based on currently available data, the results are promising, but not conclusive.  
Table 17 Signature Protein Spots 
Produced by P.putida KT2440 Grown on Phenylethylamine 
Signature Protein Spot 
 
1 2 3 4 5 6 
Figure 21 + + + + + + 
Figure 22 + + - - + + 
Figure 23 + + + - + - 
Figure 24 + + + - + + 
Note:  The table was made according to the Figure 21 through 24.  
     Signal “+” represents the presence of the possible signature spot. 




1. Low reproducibility 
As noted in the Introduction section, reproducibility is one of the problems still to 
be solved in the method of 2-DE. The poor reproducibility was also mentioned by 
Reardon et al. in an article focusing on the protein patterns expressed by P.putida F1 
grown on aromatic compounds [29]. This hampers the wider application of the technique. 
However, in a pilot study there exist a lot of variations to be fixed, among which some 
can be easily identified while others are either still unknown or beyond currently 
available techniques. Therefore, low reproducibility is fairly common and also tolerable.  
According to the experience we obtained in this project, some factors can be 
related to the low reproducibility, which could contribute to the improvement. The most 
promising candidate is that tiny bubbles existed during SDS-PAGE. After IEF, the IPG 
strips were immersed in equilibrium buffer I and II successively for 10 minutes each, 
both of which are composed of glycerol, urea, SDS, Tris/HCl and water. SDS is an ionic 
detergent able to create lather when used in household products such as toothpastes, 
shampoos and bubble baths. Herein, SDS is used to denature protein. During the process 
of equilibration small bubbles adsorb on the surface of polymer in the IPG strip. When 
the IPG strip is overlaid on top of the precast gel with agarose, elimination of these 
visible bubbles is a required step to obtain the best resolution. However, there existed 
some bubbles that are either too small for optical check or visible but hard to remove. 
Although some are too small to see, they are big enough to block the migration of 
proteins through the pores of precast polyacrylamide gel, especially those proteins with 
small size or in low abundance. In addition, before the agarose solidified they could 
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migrate freely such that these bubbles appear randomly. As a result, certain protein spots 
could be detected in one gel while the same spot did not show in another gel, as seen with 
protein spots 3 and 6 in Figure 20 through 23, they showed up in three images out of four. 
Since the occurrence of bubbles in this step is random and the elimination of those 
bubbles depends largely on the performance skills of the technician, a systematic method 
needs to be developed to ensure consistency in eliminating or, at the very least, 
minimizing this problem.    
The other possible reasons for inconsistency occurred during the step of 
rehydration. In this project, the protein samples were uploaded by a passive method. 
Protein samples were mixed with rehydration buffer in a micro-centrifuge tubes first, 
then the mixture was spread in a lane of a clean rehydration tray; the IPG strip was laid 
with the polyacrylamide gel side facing down and left at room temperature for 16 hours 
so that the protein sample could be absorbed into the pores of the gel. It was assumed that 
the IPG strip was saturated with the protein sample. However, the observation of the real 
gels revealed the fact that it was not true for all cases because even the gels from the 
protein sample prepared on the same date were observed to be somewhat lighter or darker 
after being stained and washed. This factor indicated that the extent of absorption were 
not constant as expected. There is another type of rehydration method, called active 
rehydration, which has not been tried in this project. The PROTEAN® IEF cell can also 
be programmed for this alternative. This should be tried to see whether it could improve 
the reproducibility.  
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2. Image treatment 
After the gels are stained they are dried, scanned and converted to digital files. 
Variations in these steps cause problems with the comparisons of the gels. In this project, 
the stained gels were dried by making a “sandwich”, which was pressed under several 
books totally weighing 4 to 5 pounds. The weight of books was not precisely controlled 
which led to variations in expansion and shrinkage of the gels. Furthermore, gels dried in 
this manner still retain some water. The incompletely dried gels are neither suitable for 
storage over a long period nor conveniently kept well enough for scanning. The 
remaining water made the gels stick on the cellophane, consequently affecting the quality 
of scanned images with the reflection from the cellophane. Because parts of a gel were 
dried while parts were moist, the gels were susceptible to breakage when the cellophane 
was removed for scanning. A better, more systematic approach to dehydrate and store 
gels will contribute greatly to the improvement of image quality. A machine specifically 
designed for desiccation can be a good choice, for example, GelAirTM drying system 
manufactured by Bio-Rad is one of the options.   
The protein patterns found on the gels were converted to digital files through a 
series of steps described in the Experimental section. The first and most important step is 
the scan. A flat scanner was used whose resolution is not high enough to transfer all the 
information on the gels, especially faint spots that represent proteins with low expression 
levels. On the other hand, another factor associated with the effect of scanner, which 
could be easily ignored, is the presence of background staining in the gel which did not 
represent protein.  Since the slight difference in the clarity of the gel background is hard 
to distinguish by vision without help of instrument or facilities, this factor is often 
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neglected. Actually, it also affects the image quality because the delicate difference is 
often magnified during scanning-the filtering and processing performed by human eyes 
and brains is not replicated by the scanner. Increased background levels can interfere with 
analysis of the gels. The gels obtained in this project were compared to those obtained in 
another project, which was designed to apply 2-DE for the comparison of protein patterns 
expressed by P.putida F1 in different carbon sources. Direct visual observation of the 
gels did not reveal that the background of one gel was clearer than that of another one. 
Nevertheless, the digital images revealed those differences in background. The devices 
used to convert gel images to digital file are of concern. The most commonly used 
devices are camera systems, densitomerters, phosphor imagers, and fluorescence scanners. 
Some image acquisition devices serve for the conversion of gels into data and contribute 
to the quality of the results, such as the flat scanner used in this project. The flat scanner 
significantly pre-determines the final quality of analysis. A series of image acquisition 
instruments designed specifically for certain stain are commercially available. 
Information carried by Bio-SafeTM Coomassie stained gels can readily be converted by 
VersaDocTM Model 5000 and Model 3000 imaging systems as well as GS-800 calibrated 
imaging densitomer, all of which are supplied by Bio-Rad.  
The third source of error closely associated with the data analysis is that the 
digital files have to undergo further conversion steps in order to be recognized by the 
Progenesis software. The protein spots on the gels were stained blue by Coomassie Blue 
G-250, while the images to be analyzed by the Progenesis must be in a black and white 
format. After the conversion of color to black and white, many of the faint spots on the 
gel were lost or later interpreted as contamination by the Progenesis software.  
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3. Identification of possible signature protein 
Figure 25 was taken from Figure 4, demonstrating the comparison of putative 
pathways by P.putida KT2440 to degrade phenylethylamine and succinic acid 
respectively. Dissociation constants of succinic acid are 4.21 and 5.64 [58]. The pH value 
of Hutner’s medium is around neutral such that the succinic acid converts to succinate 
when added to Hutner’s medium then participates into the citric acid cycle (TCA cycle in 
Figure 25) directly. Details of TCA cycle are included in Appendix C. The metabolism of 
succinic acid is simpler than that of phenylethylamine because it does not require 
involvement of pha gene products (see Figure 25 and Table 4). When phenylethylamine 
is the carbon source, it is essential for the strain to produce corresponding proteins for 
digestion. These specific proteins which are supposed to be expressed only in response to 
phenylethylamine are called signature proteins. Herein, the signature proteins were 
expected, especially the protein(s) which functioned to break the benzene ring of 
phenylethylamine.  
With the help of Progenesis software, a series of signature protein spots (1, 2, 3, 5 
and 6 indicated in Figure 21 through 24) were found in this project.  However, some were 
quite faint on the gel images. All of them were located in the acidic pH range (4-6), low 
molecular weights (spot 1, 2, and 3) to medium range (spot 5 and 6). But the spot 
intensities were not strong enough to be conclusive. In addition to the reasons mentioned 
above in the subtitles of Low Reproducibility and Image Treatment, another cause for the 
faintness of the spots could be that the proteins were extracted at approximate mid-log 
phase when the amount of predicted signature proteins had not reached a high enough 




Figure 25 Putative pathways of P.putida KT2440 to degrade phenylethylamine and 
succinic acid [26]
 
beginning of the stationary phase may produce stronger signals adequate for further  
manipulation and analysis. 
The setting of contrast color provided by the software Progenesis is also related to 
the faintness. The software uses three different sets of color contrast to represent 
reference gel-slave gel: magenta-green, yellow-blue, cyan-red. The setting of yellow-blue 
makes the spots on the slave gel clearly observed while the spots on the reference gel too 
light to undergo comparison and manual warping. In contrast, the setting of cyan-red 
makes the spots on the reference gel clear however the spots on the slave gel obscure. 
Among the three sets of color contrast, magenta-green gave the best effect.  
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In addition, the software Progenesis is a large workstation for image analysis. The 
system is fairly complicated, which requires certain amount of time of practice to be 
familiar with the functions. More training for the manipulation of the workstation would 
be beneficial.  
 
4. Proteins in smear 
 There was a group of proteins found on all the gels which shared the properties of 
basic pI values between 8 and 10 as well as low molecular weight. Their intensity in the 
figures revealed that the amount of this group of proteins was high. Another interesting 
feature is that they were all expressed when the strain was grown on different carbon 
sources. It is speculated that this group of proteins are fundamental for growth of the 
strain in different environments, i.e., it is highly likely that they are the proteins involved 
in TCA cycle. The existence of this group of proteins indicates that IEF with pH 3-10 
IPG strip cannot supply high enough resolution to separate them. An IPG strip with an 
extended pH range such as pH 7 to 10 might be effective in resolving this group of 
proteins with very close pI values. Another possible reason is the incompatibility of this 
group of protein with the IEF process, which is seen in hydrophobic proteins. Their 
marginal solubility leads to protein precipitation and aggregation. In this case, 
modification of the sample buffer to increase solubility of this kind of proteins is the most 
direct and efficient way to solve the problem, such as adding reagent 3 of sequential 
extraction solution supplied by Bio-Rad, which contains multiple surfactants (Table 9.6 
and 9.7 in 2-D Electrophoresis for Proteomics, A Methods and Product Manual [60]).  
These proteins may not be the targets of this project, therefore the concern on 
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further resolution of this group of special proteins will not be covered here. On the other 
hand, the identification of these proteins could provide the supporting evidence to verify 
the putative degradation pathway as shown in Figure 25, in particular the convergence to 
TCA cycle with the pathway for phenylethylamine degradation.  
 
5. Further studies 
This project is foundational to a pilot study which will explore developing a new 
and more effective method for carcinogen screening based on proteomics. To this point, 
the setup of a complete protocol has been largely complete, i.e., starting from the 
selection of biological model to analysis of separated protein extracts by 2-D gel. The 
final steps for the protocol should include procedures which focus on identifying these 
possible “signature protein” spots. Candidate spots can be extracted from gels and 
digested by an enzyme, such as trypsin, then analyzed by combined mass spectrometry 
technology for identification. Generally, two different types of instrument combinations 
are used: Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass 
Spectrometry and Electrospray Ionization Mass Spectrometry. They operate in distinct 
ways and generate different but complimentary information.  
MALDI-ToF MS was developed for the analysis of relatively large polypepetides 
and proteins. It is compatible with new robotic sample preparation devices designed to 
aid high-throughout proteomics work. The major advantage of MALDI-ToF MS is that 
the process of ionization generates little or no fragmentation of analytes, allowing the 
ions of analytes to be identified even in mixtures [62]. The standard approach is to digest a 
protein, analyze the peptide fragments for molecular weight and then compare those 
 93
molecular values to fragment sizes predicted by online MS database tools such as 
PeptideMass [70]. However, MALDI-ToF MS is best-suited for measurement of peptide 
masses, which is limited for protein identification. While MALDI-ToF MS can be very 
helpful in identifying peptide fragments from organisms whose genomes have been fully 
sequenced, it is not appropriate to provide peptide ion fragmentation which gives true 
sequence data. In addition, MALDI-ToF MS analysis is highly dependent on the quality 
of the sample. Contamination of the sample with significant levels of detergents, buffer 
salts, metals may greatly inhibit peptide ionization in the MALDI source [62]. ESI MS is 
able to supply the information which is unavailable from MALDI-ToF MS analysis, i.e., 
peptide ion fragmentation which leads directly to protein sequence determination for 
protein identification. 
Once the protocols for protein separation and identification are fully established, 
the next step is to look for a “carcinogenic protein signature” in P. putida. As the 
signature proteins in response to phenylethylamine are unequivocally identified, they will 
be compared to signature proteins that are expressed in response to other aromatic 
compounds and known carcinogens, in particular.  If a set of signature proteins consisting 
of 5 to 10 protein spots on 2-DE gels can be clearly and consistently identified when 
P.putida KT2440 is grown on a known mutagen or carcinogen, we can develop a basis 
for screening. Once such a signature is established, the strain will be grown on a 
compound of unknown carcinogenicity under standard conditions.  Then the proteins will 
be extracted and searched for the signature proteins by comparison to the known 
carcinogenic signature.  
A second approach could be based on the specificity of antibodies to antigens.  
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Herein, the signature proteins will be the antigens. Once the signature proteins are 
identified, they will be used to raise monoclonal antibodies in laboratory mice, using 
standard protocols. Injection of antigen to mice via intraperitoneal or subcutaneous route 
is followed by excision and manipulation in vitro of spleen to collect hybridoma cells 
producing appropriate monoclonal antibody. The second batch of mice receive an 
intraperitoneal injection of diluted hybridoma cells, whose ascetic fluids are collected 
containing designed antibody in relatively large amount [71]. An enzyme-linked 
immunosorbent assay (ELISA) will then be designed to detect and quantify proteins of 
interest. ELISAs can be further classified as indirect and direct. Indirect ELISAs are used 
to detect the presence of antibody to the antigen, the signature proteins. The direct ELISA, 
also called sandwich ELISA, allows both the detection and the quantitation of antigen [49].   
In this protocol, the target antigens will be the signature proteins produced by the 
strain P. putida KT2440. In the presence of the antigen, the antibody component of 
antibody-enzyme complex will bind to it and the enzyme component of the complex will 
catalyze the conversion of the colorless substrate to a colored product. The emergence of 
the colored product will indicate the presence of the antigen. The rate of reaction in the 
direct ELISA is proportional to the amount of antigen, permitting the measurement of 
small quantities of antigen. The ELISA is a rapid, convenient method with high 
sensitivity of less than 10-9 grams of antigen. The creation of a set of 10 screening assays, 
based on the carcinogen signature proteins will provide a high level of reliability (low 





 This project is a pioneer work of creating an alternative to the Ames test in 
screening for mutagens and/or carcinogens. A proteomics approach provides information 
on how the test strain responds to the different mutagens/carcinogens, which has great 
promise to ultimately lead to a more reliable test.  
 In the project, the following series of standard procedures as well as the 
preparation of reagents have been successfully set up and verified by experiments:  
• inoculation of strain stock solution to isolate single colonies;  
• growth of cells in Hutner’s medium with different carbon sources at fixed 
concentration; 
• determination of growth curves, harvest of cells at designated growth time, 
fractionation of harvested cells to extract soluble proteins and collection of the 
crude extract; 
• ribonuclease treatment to minimize contamination caused by RNA;  
• protein assays to determine the protein concentrations;  
• rehydration of IPG strips; 
• IEF to separate proteins in the first dimension separation;  
• equilibration of IPG strips after IEF, SDS-PAGE to separate proteins in the 
second dimension separation;  
• staining of gels for visualization;  
• drying gels;  
• conversion of real gels into digital files; 
• analysis of protein patterns with the help of software Progenesis.  
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The data obtained in the determination of growth curves and protein assay are 
reproducible. The results indicated that further improvements are necessary, particularly 
in the imaging and analysis stages.  
Although the problem of reproducibility in 2-D gel images has not been solved in 
this project, the results revealed the presence of several signature proteins after 
comparing the images from the same strain grown in different carbon sources.  
 
Future work 
Because of the importance of the reproducibility in the application of 2-DE, this 
project provided several clues for improvement. 
1. Collect proteins at the beginning of stationary phase 
In mid-log phase, the growth rate is much greater than the death rate. To keep up 
with the fast growth rate, more carbon source is consumed meanwhile the proteins 
working to digest the carbon source are accumulating. The amount of proteins, especially 
those degrade phenylethylamine, may not be saturated until the stationary phase. In 
stationary phase, the equilibrium between the cell growth and cell death is reached. The 
concentration of proteins reaches the highest level. It is suggested that samples be 
collected at the beginning of stationary phase because there is not too much waste in the 
culture at that time. The accumulated waste substances are not only poisonous to the cells 
but also supposed to complicate the composition of sample for separation by 2-DE.  
2. Change to use silver stain or other stains  
With a high sensitivity of 0.1 ng per mm2 of gel, silver stain is well suited for 
identifying proteins of interest in low abundance. It is 10 to 50 fold more sensitive than 
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Coomassie Brilliant Blue R-250 [64], but it is not compatible for MS analysis. There are 
other options like SYPRO Ruby, SYPRO Orange.  
3. Drying gel with designed apparatus 
This manipulation should reduce gel warping in order to match, as mentioned in 
the Discussion section. 
4. Improvement in the quality of digital files of real gels 
The flatbed scanner commonly used in an office is unable to supply high enough 
resolution to carry the delicate information on the gels. A densitometer or fluorescent 
imager manufactured by Bio-Rad would be a better choice. Different imagers are 
compatible for specific stains. For example, a densitometer can detect gels stained by 
Coomassie R-250, Bio-Safe Coomassie stain and silver stain. It is, however, unable to 
detect gels stained by SYPRO Ruby or SYPRO Orange.  
5. Rapid analysis of images after any change occurs 
During the journey from a single colony grown in a Petri plate to protein pattern 
indicated in a 2-DE gel, there exist many variations, each of which contributes to the 
image to be analyzed. To evaluate the effect of every modification, visual observation is 
not always enough to distinguish the difference although sometimes it works. In case 
there is no significant difference observed visually after a change, it is better to analyze 
using software to confirm. 
6. Comparison of results using different software 
In this project, only Progenesis software was applied for analysis. Reardon et al. 
analyzed the images in their research by Phoretix 2D software which is also licensed  by 
Nonlinear. Signature proteins which are identified by more than one software are more 
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reliable. Other software to analyze 2-DE gels are ProteomWeaver from Definiens 
(http://www.definiens.com/proteomweaver/index.htm) and ProteinMine from Scimagix 
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Solution A: per liter deionized H2O: 
 Na2HPO4 141 .2 g 
 KH2PO4 136 g 
 (shou1d give pH=7.25) 
 
Solution C: per 1iter deionized H2O: 
                                                           (NH4)2SO4                            200 g 
 
 
Metals 44 Solution: 
                 In 800mL deionized water, dissolve: 
      EDTA   2.50  g 
ZnSO4 • 7H2O  10.95g 
MnSO4 • 7H2O  1.54  g 
FeSO4 • 7H2O  5.00  g 
CuSO4 • 5H2O   392 mg 
Co(NO3)2 • 6H2O           248 mg 
Na2B4O7 • 10H2O  177 mg 
 
Add d few drops of concentrated H2S04 to retard precipitation. Make to a volume of 1 L. 
The solution is a clear lime green, and it keeps indefinitely. Store it in a brown glass bottle at room 
temperature in a cabinet. 
 
Solution B: Hutner’s Base 
per liter deionized water: 
 Nitrilotriacetic acid (NTA) 10 g 
 MgSO4 14.45 g (or 29.56 g MgSO4• 7H2O) 
 CaCl2• 2H2O 3.33 g 
 (NH4)6Mo7O24• 4H2O 9.25 rng 
 FeSO4 • 7H2O 99 mg 
 Metals 44 50 mL 
 
I usually made up 4 L at a time with the following procedure: 
1. Dissolve 40 g nitrilotriacetic acid in about 2.5—3 liters water. This is easier if the water 
is hot when adding the NTA. Heating the water to boiling is OK and it seems to help. BE 
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CAREFUL WITH NTA! THIS COMPOUND IS KNOWN TO CAUSE HEREDITARY 
GENETIC DAMAGE! Our original instructions said to neutralize this with 7.3 g/L KOH, but we 
found that this step leads to an insoluble precipitate, so we do not do this. 
2. Dissolve 118.24 g MgSO4•7H2O in about 300 mL water. Again, heat may help to 
dissolve it. 
3. Dissolve 13.32 g CaCl2•2H2O in 100 mL water 
4. Dissolve 37 mg ammonium molybdate and 396 mg FeSO4•7H2O together in 100 mL 
water. 
5. Add the magnesium sulfate solution to the NTA solution slowly while stirring (use a 
teflon stir bar) and be careful to avoid any clouding of the mixture. Once these are mixed, 
gradually add the calcium chloride solution. Then add the remainning solution. The mixture 
should now be a yellow color. Now add 200 mL Metals 44 solution. The solution should be a 
deeper yellow color. 
6. Bring the volume up to 4 liters and have a pH probe and meter inserted into the liquid. 
Bring the pH up to about 6.7 with 10 N NaOH. This must be done slowly, especially toward the 
end. You will see a transitory precipitate that dissolves eventually upon vigorous stirring. Let 
precipitate dissolve before adding more NaOH. If the pH goes over 7, the solution will turn a 
green/gray and precipitate will form. I have done this and salvaged the solution by adding a drop or 
two of concentrated H2SO4 and then again adding NaOH until the pH got to 6.7 
 
 All medium component solutions were vacuum-filtered through Whatman qualitative filter 
paper before storage in order to remove any particulate matter. 
 
To prepare 1 liter of MSB: 
    Solution A  40 mL 
    Solution B  20 mL  
    Solution C   5   mL 
 
 A heavy precipitate will form upon autoclaving. It will dissolve as the medium is stirred 
while cooling.  
 We have found that if the following components are autoclaved separately:  
1. Water,  
2. Solution A, and  
3. Solution B & C together, 
and then combined after cooling, that no precipitate will form and lots of time can be saved in the 
lab. 
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Appendix B: Glossary 
 
Allele An alternative form of a gene. One of the different forms of a gene that 
can exist at a single locus (spot on a chromosome). Also one of the 
different forms of any segment of a chromosome. [2] 
Aneuploidy One or a few chromosomes more than (hyperploidy, as in Down 
syndrome) or fewer than (hypoploidy, as in Turner’s syndrome) the 
normal chromosome number. [2] 
Carcinogen  Substances that increase the risk of neoplasms in humans or animals. 
Both genotoxic chemicals, which affect DNA directly, and 
nongenotoxic chemicals, which induce neoplasms by other mechanism, 
are included. [2] 
Carcinogenic Causing cancer or contributing to the cause of cancer. [2] 
Carcinogenesis The process encompassing the conversion of normal cells to neoplastic 
cells and the further development of neoplastic cells into a tumor. [1] 
Chromatids One of the paired chromosome strands, joined at the centromere, which 
make up a metaphase chromosome, resulting from chromosome 
reduplication during the S phase (DNA synthetic phase) of interphase. 
[2] 
Copiotrophic The growth medium is nutrient rich in its composition. [2] 
Cytogenetics  A fusion science due to joining of cytology (the study of cells) with 
genetics (the study of inherited variation). [1] 
Endocarditis Exudative and proliferative inflammatory alterations of the 
endocardium, usually characterized by the presence of vegetations on 
the surface of the endocardium or in the endocardium itself, and most 
commonly involving a heart valve, but sometimes affecting the inner 
lining of the cardiac chambers or the endocardium elsewhere. It may 
occur as a primary disorder or as a complication of or in association 
with another disease. [2] 
Expressed Sequence 
Tag (EST) 
A unique stretch of DNA within a coding region of a gene that is useful 
for identifying full-length genes and serves as a landmark for mapping. 
An EST is derived from cDNA. [3] 
Genome (gene + 
chromosome)   
 
1. the complete gene complement of an organism, contained in a set of 
chromosomes in eukaryotes, a single chromosome in bacteria, or a DNA 
or RNA molecule in viruses.   
2. the full set of genes in an individual, either haploid (the set derived 
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from one parent) or diploid (the double set, derived from both parents). 
In a human being the haploid set contains about 3 billion base pairs of 
DNA and 50,000–100,000 genes.[2] 
Genomics 
 
The study of genes and their function. Genomics aims to understand the 
structure of the genome, including the mapping genes and sequencing 
the DNA. Genomics examines the molecular mechanisms and the 
interplay of genetic and environmental factors in disease. [2] 
Genotoxic Damaging to DNA, thereby causing mutations or cancer. [2] 
Glenders: A contagious disease of horses, communicable to humans. The acute 
form is marked by a purulent inflammation of mucous membranes and 
an eruption on the skin of nodules that coalesce and break down, 
forming deep ulcers that may end in necrosis of cartilages and bones. [2]
Huntington’s disease An inherited condition characterized by abnormal body movements, 
dementia, and psychiatric problems. [2] 
Mineralize To convert into mineral or inorganic form. [1] 
Mutagen Something capable of causing a gene change. Among the known 
mutagens are radiation, certain chemicals and some viruses. [2] 
Mutagenic Inducing genetic mutation. [1] 
Mutagenesis An event capable of causing mutation. [1] 
Mutation A permanent change, a structural alteration, in the DNA or RNA [2]  
Nonsister chromatids The two chromatids of one homologous chromosome with respect to 
those of the other homologue. [2] 
Open reading frame A long sequence of DNA that has no stop codon (no signal to stop 
reading) and therefore may encode part or all of a protein. [2] 
Opportunistic Causing disease only when the immune system of the host has been 
weakened, or other damage to the host provides special opportunity for 
invasion. AIDS predisposes a patient to opportunistic infection.[1] 
Pathogenic Giving origin to disease or to morbid symptoms. [2] 
Phenotype 
 
The appearance of an individual, which results from the interaction of 
the person's genetic makeup and his or her environment. By contrast, the 
genotype is merely the genetic constitution (genome) of an individual. 
For example, if a child's genotype includes the gene for osteogenesis 
imperfecta (brittle bone disease), minimal trauma can cause fractures. 
The gene is the genotype, and the brittle bones themselves are the 
phenotype. [2] 
Proteome (PROTEin The complete set of proteins expressed and modified following their 
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+ genOME) expression by the genome. [2] 
Proteomics: The study of the proteome, the complete set of proteins produced by a 
species, using the technologies of large-scale protein separation and 
identification. The term proteomics was coined in 1994 by Marc 
Wilkins who defined it as "the study of proteins, how they're modified, 
when and where they're expressed, how they're involved in metabolic 
pathways and how they interact with one another." [2] 
Saprophytic: Feeding or growing upon decaying animal or vegetable matter; 
pertaining to a saprophyte or the saprophytes. [2] 
Sister chromatids The two chromatids of a chromosome held together by a centromere; 
dyads. [2] 
Transposon a small mobile genetic (DNA) element that can move around within the 
genome or to other genomes within the same cell, usually by copying 
itself to a second site but sometimes by splicing itself out of its original 
site and inserting in a new location. Complex transposons may carry 
other genes besides merely those for transposition. Transposons are 
sometimes called transposable elements.[2] 
Xenobiotic A chemical foreign to the biologic system [2] 
Xeroderma 
pigmentosum 
a rare pigmentary and atrophic autosomal recessive disease affecting all 
races, in which there is extreme cutaneous photosensitivity to ultraviolet 
light, as a result of a deficient enzyme in the excisional repair of 
ultraviolet-damaged DNA. [2] 
Wild-type The genotype or phenotype that is found in nature or in the standard 
laboratory stock for a given organism. The phenotype of a particular 
organism when first seen in nature. [2] 
[1] Webster Dictionary 
[2] Dorland’s Illustrated Medical Dictionary 
[3] MedTermTM Dictionary at http://www.medterms.com/script/main/art.asp?articlekey=3328 
accessed on July 21, 2005 
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Appendix C: TCA Cycle (Krebs cycle) 
 
TCA cycle (Krebs cycle) [59]
 110






Appendix E: Regression Analysis 
Each calibration curve is determined by modified Bio-Rad protein assay. Table 18 
shows the raw data of such a typical assay.  
Table 18 Raw data of modified Bio-Rad protein assay, bovine gamma globulin 
Serial No. 
Volume of stock 
standard protein
(µl) 




1 0 0.000 0.464
2 5 0.715 0.615
3 10 1.430 0.723
4 15 2.145 0.890
5 20 2.860 1.020
6 30 4.290 1.198
7 40 5.720 1.335
8 50 7.150 1.473
9 60 8.580 1.538
10 70 10.010 1.636
11 80 11.440 1.666
12 90 12.870 1.740
13 100 14.300 1.821
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Figure 26 Plot of absorbance versus final concentration of standard protein 
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The trend of the points indicates a possible linear curve. However, the regression 
analysis by Microsoft Excel verifies that actually it is not linear, see Table 19.  
Table 19 Regression Analysis by Microsoft Excel 
SUMMARY OUTPUT     
      
Regression Statistics     
Multiple R 0.96349102    
R Square 0.92831495    
Adjusted R Square 0.92179813    
Standard Error 0.12791384    
Observations 13    
      
ANOVA      
  df SS MS F Significance F
Regression 1 2.330743481 2.330743481142.4490105 1.22984E-07
Residual 11 0.179981442 0.016361949  
Total 12 2.510724923      
 
  Coefficients Standard Error t Stat P-value 
Intercept 0.66922561 0.05954001 11.23993112.27243E-07
X Variable 1 0.09102033 0.007626209 11.935200481.22984E-07
 
First, the R square term does not look promising as it is expected.   
The second evidence indicative of the nonlinear character is the intercept. Its 
value as compared with the error (0.669±0.060) does not include the first point, the 
absorbance of 0.464 when no standard protein is added. The curve might have a higher 
intercept than 0.464 but since the absorbance at this point was measured and recorded, 
which convinced that the calibration curve should go through this particular point.  
The third evidence supporting the nonlinearity is the residuals. The residual 
values are the difference of the fitted point from the experimental points, (yfit value-






Table 20 Residual Values by Microsoft Excel 
RESIDUAL OUTPUT    
     
Observation Conc. µg/µl Abs.595 Predicted Y Residuals 
1 0.000 0.464 0.66922561 -0.205225608
2 0.715 0.615 0.73430514 -0.119305144
3 1.430 0.723 0.79938468 -0.07638468
4 2.145 0.890 0.86446422 0.025535784
5 2.860 1.020 0.92954375 0.090456248
6 4.290 1.198 1.05970282 0.138297176
7 5.720 1.335 1.1898619 0.145138105
8 7.150 1.473 1.32002097 0.152979033
9 8.580 1.538 1.45018004 0.087819961
10 10.010 1.636 1.58033911 0.055660889
11 11.440 1.666 1.71049818 -0.044498183
12 12.870 1.740 1.84065725 -0.100657255
13 14.300 1.821 1.97081633 -0.149816327
            Fit point = slope * X + intercept 
  
 The trend shown by the plot of residues against the concentration can reveal a 
relationship.  
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Figure 27 Plot of Residual Values vs. Concentration of Standard Protein 
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The residue values in the plot showed a curved trend, i.e., the best fit linear line 
pass above the actual data in the midrange and do the opposite at the extremes. If the best 
fit line is curved or the deviations are made up from noise only, there should not be such 
a trend as seen above. The noticeable trend shown in the plot indicates the nature of 
nonlinearity of calibration curve of protein assay.  
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